<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Neuropathol</journal-id><journal-id journal-id-type="iso-abbrev">Acta Neuropathol</journal-id><journal-title-group><journal-title>Acta Neuropathologica</journal-title></journal-title-group><issn pub-type="ppub">0001-6322</issn><issn pub-type="epub">1432-0533</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407905</article-id><article-id pub-id-type="pmc">PMC12102137</article-id>
<article-id pub-id-type="publisher-id">2862</article-id><article-id pub-id-type="doi">10.1007/s00401-025-02862-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Sequence and trajectory of early Alzheimer&#x02019;s disease-related tau inclusions in the hippocampal formation of cases without amyloid-&#x003b2; deposits</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6776-1045</contrib-id><name><surname>Braak</surname><given-names>Heiko</given-names></name><address><email>heiko.braak@uni-ulm.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1042-9006</contrib-id><name><surname>Mayer</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0003-0470-0063</contrib-id><name><surname>Feldengut</surname><given-names>Simone</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8905-1810</contrib-id><name><surname>Sch&#x000f6;n</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9130-7838</contrib-id><name><surname>Del Tredici</surname><given-names>Kelly</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/032000t02</institution-id><institution-id institution-id-type="GRID">grid.6582.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9748</institution-id><institution>Department of Neurology, Center for Biomedical Research, Clinical Neuroanatomy, </institution><institution>University of Ulm, </institution></institution-wrap>Helmholtzstrasse 8/1, 89081 Ulm, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/032000t02</institution-id><institution-id institution-id-type="GRID">grid.6582.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9748</institution-id><institution>Institute of Epidemiology and Medical Biometry, </institution><institution>University of Ulm, </institution></institution-wrap>89075 Ulm, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/032000t02</institution-id><institution-id institution-id-type="GRID">grid.6582.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9748</institution-id><institution>Institute for Anatomy and Cell Biology, </institution><institution>University of Ulm, </institution></institution-wrap>89081 Ulm, Germany </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>149</volume><issue>1</issue><elocation-id>50</elocation-id><history><date date-type="received"><day>19</day><month>7</month><year>2024</year></date><date date-type="rev-recd"><day>28</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>28</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Sporadic Alzheimer&#x02019;s disease (AD) involves specific neuronal types and progresses in a systematic manner, permitting subdivision into six neuropathological stages. Neurofibrillary tangle (NFT) stages I&#x02013;III display abnormal tau inclusions confined to subcortical nuclei and temporal allocortical regions, frequently without amyloid &#x003b2; (A&#x003b2;) deposition. We previously suggested a sequence of neuronal involvement in AD that could proceed from entorhinal pre-&#x003b1; cells to hippocampal prosubicular pyramidal cells and the CA1/CA2 sectors, from there to the thorny excrescences on mossy cells in CA3/CA4, and, finally, from the mossy cells to dentate fascia (Fd) granular cells. Here, we aimed to see if associations existed between the early NFT stages I&#x02013;III, when A&#x003b2; deposits are frequently absent, and the following four categories: (1)&#x000a0;anatomical regions and abnormal morphological tau changes in region-specific layers, (2) nerve cell loss, (3) APOE genotype, and (4) the trajectory (directionality) of tau progression in the hippocampal formation. To do so, we examined the transentorhinal/entorhinal regions and hippocampal formation using AT8-immunohistochemistry in 100&#x000a0;&#x000b5;m sections from <italic>N</italic>&#x02009;=&#x02009;308 brains with tau inclusions lacking A&#x003b2; deposits between NFT stages I and III (average age at death 66.7&#x000a0;years for females, 66.4&#x000a0;years for males). Our results indicated a significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) ordered progression of abnormal tau in a direction opposite to currently known unidirectional intrahippocampal connections, thereby indirectly supporting the idea of transneuronal abnormal tau spreading, i.e., anterogradely, through the hippocampal formation. Tau-related neuronal loss was also significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for the transentorhinal/entorhinal regions and for sectors CA1/CA2 and <italic>p</italic>&#x02009;=&#x02009;0.003 for CA3/CA4/Fd). These findings challenge the amyloid cascade and the PART hypotheses, corroborating the concept that early AD-related tau inclusions and tau-related neuronal loss occur independently of A&#x003b2; deposition.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00401-025-02862-x.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Alzheimer&#x02019;s disease</kwd><kwd>AT8</kwd><kwd>Cornu ammonis</kwd><kwd>Dendritic tau</kwd><kwd>Entorhinal region</kwd><kwd>Fascia dentata</kwd><kwd>Ghost threads</kwd><kwd>Hippocampal formation</kwd><kwd>Neuronal loss</kwd><kwd>Neurofibrillary tangles/neuropil threads</kwd><kwd>Neuron-to-neuron transmission</kwd><kwd>Perinuclear rims</kwd><kwd>Pretangle</kwd><kwd>Thorny excrescences</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017518</institution-id><institution>Hans und Ilse Breuer-Stiftung</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Universit&#x000e4;t Ulm (1055)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Sporadic Alzheimer&#x02019;s disease (AD) is a chiefly homogeneous human tauopathy, which preferentially involves late-developing and late-maturing projection neurons of the central nervous system that generate a long and late-myelinating axon [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR112">112</xref>]. The pathological process begins early in life without extracellular amyloid &#x003b2; (A&#x003b2;) deposition [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par3">AD-related brain changes include the abnormal and AT8-immunopositive tau protein in the form of partially soluble and non-fibrillar pretangles that subsequently form argyrophilic fibrils and then neuropil threads in dendrites (NTs), and neurofibrillary tangles (NFTs) in cell somata [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR120">120</xref>]. By contrast, abnormal tau in axons usually resists conversion into insoluble and fibrillar tau [<xref ref-type="bibr" rid="CR23">23</xref>]. Axonal seeds of pretangle tau are thought to transfer the pathology anterogradely from involved nerve cells to uninvolved neurons through axonal connectivities [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>].</p><p id="Par4">The predictable regional pattern of the tau inclusions in the brain permits the distinction of neuropathological stages [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]. Initially, cortical tau changes remain virtually confined to the medial temporal lobe and, notably, they usually develop in the absence of A&#x003b2; deposition. The abnormal tau inclusions are invariant characteristics of the early AD-related process and are necessary for the development of the following disease stages that ultimately result in clinically detectable phases of AD [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR116">116</xref>].</p><p id="Par5">Known anatomical connectivities within the temporal allocortex include portions of the perforant path that are generated from the outer layers of the entorhinal region and head towards the dentate fascia (Fd) [<xref ref-type="bibr" rid="CR6">6</xref>] (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, blue connections). From there, axons of dentate granular cells (mossy fibers) contact projection neurons of CA4/CA3 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, light red). Schaffer collaterals connect to CA1 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, dark red), and the ammonic-subicular pathway finally reaches the output region, the subiculum [<xref ref-type="bibr" rid="CR70">70</xref>] (Suppl. Fig.&#x000a0;1). However, in a previous study, we suggested a sequence of neuronal involvement in AD that could proceed in the opposite direction, namely, from the entorhinal region to the hippocampal prosubiculum and CA1/CA2 sectors, then to the thorny excrescences and mossy cells in CA3/CA4, whence it reaches the dentate granular cells [<xref ref-type="bibr" rid="CR25">25</xref>].<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Summary diagram of allocortical connectivities of the temporal lobe. Outer layers of the entorhinal and transentorhinal regions project via the perforant path (<italic>blue connections</italic>) to the Ammon&#x02019;s horn and predominantly to the dentate fascia (Fd). Granule cells of the dentate fascia project via mossy fibers to excrescences of multipolar cells in CA4 and pyramidal cells in CA3 (<italic>light red connections</italic>). Axons of CA3 pyramidal cells give off Schaffer collaterals to dendrites of CA1 pyramidal cells in the stratum lacunosum and stratum oriens (<italic>dark red connections</italic>). CA1 pyramidal cells project via the ammonic-subicular pathway (not shown) to the subiculum, and subicular efferents reach the deep layer pri-&#x003b1; of the entorhinal region and the alveus (<italic>dark red connections</italic>)</p></caption><graphic xlink:href="401_2025_2862_Fig1_HTML" id="MO1"/></fig></p><p id="Par6">Here, we present a hypothetical route of potential tau spreading through allocortical portions of the temporal lobe and point to its importance for the early AD pathological process using AT8-immunostained sections from the transentorhinal/entorhinal regions and hippocampal formation from <italic>N</italic>&#x02009;=&#x02009;308 autopsy brains. We asked if associations existed between the early NFT stages I&#x02013;III when A&#x003b2; deposits are absent and the following four categories: (<bold>1</bold>)&#x000a0;anatomical regions and local layers (laminae) with abnormal morphological changes, (<bold>2</bold>) nerve cell loss, (<bold>3</bold>) APOE genotype, and (<bold>4</bold>) the here-proposed directionality (trajectory) of tau progression in the hippocampal formation.</p></sec><sec id="Sec2"><title>Material and methods</title><sec id="Sec3"><title>Study cohort</title><p id="Par7">This retrospective study was conducted in compliance with ethical principles originating in, or derived from, the latest version of the Declaration of Helsinki, Ulm University ethics committee guidelines, and with German federal and state law governing human tissue usage. Informed written permission was obtained from all patients and/or their next of kin for autopsy.</p><p id="Par8">We included brains from <italic>N</italic>&#x02009;=&#x02009;308 cognitively unimpaired individuals (CDR 0, CERAD 0 based on clinical and/or postmortem chart reviews in our University of Ulm brain bank and tissue database) of European ancestry neuropathologically staged according to previously published protocols [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. All 308 cases fit the description for definite PART (primary age-related tauopathy), i.e., cognitively unimpaired individuals (here, regardless of age) with NFT/NT stages I-VI, A&#x003b2; phase 0, and CERAD none [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR50">50</xref>].</p><p id="Par9">Brains with neuropathologically confirmed synucleinopathies or TDP-43 frontotemporal lobar dementia were excluded. Additional exclusionary criteria were the presence of A&#x003b2; deposition, hippocampal sclerosis, cerebral bleedings, epilepsy, ischemic stroke, cerebrovascular disease, or tauopathies other than AD, e.g., argyrophilic grain disease (AGD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Pick&#x02019;s disease (PiD), or chronic traumatic encephalopathy (CTE). Neuropathologic diagnoses for all excluded non-AD tauopathies had been made previously using 100&#x000a0;&#x000b5;m free-floating tissue sections and published protocols [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. Demographic and neuropathological staging data for all cases (120 females, 188 males, age range 28&#x02013;100&#x000a0;years; mean age 65.9&#x000a0;years) are summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. NFT stages I&#x02013;III according to decades (age distribution) for all cases are shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a&#x02013;c.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Early tau pathology in the absence of amyloid &#x003b2; deposits in N&#x02009;=&#x02009;308 cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Age group (yrs)</th><th align="left">NFT I</th><th align="left">NFT II</th><th align="left">NFT III</th><th align="left">Total</th></tr></thead><tbody><tr><td align="left">0&#x02013;9</td><td align="left">0</td><td align="left">0</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">10&#x02013;19</td><td align="left">0</td><td align="left">0</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">20&#x02013;29</td><td align="left"><p>3 (2f/1&#x000a0;m)</p><p>2.22%</p></td><td align="left">0</td><td align="left">0</td><td align="left"><p>3 (2f/1&#x000a0;m)</p><p>1%</p></td></tr><tr><td align="left">30&#x02013;39</td><td align="left"><p>12 (4f/8&#x000a0;m)</p><p>8.90%</p></td><td align="left">0</td><td align="left">0</td><td align="left"><p>12 (4f/8&#x000a0;m)</p><p>4%</p></td></tr><tr><td align="left">40&#x02013;49</td><td align="left"><p>26 (11f/15&#x000a0;m)</p><p>19.26%</p></td><td align="left"><p>4 (3f/1&#x000a0;m)</p><p>4.44%</p></td><td align="left">0</td><td align="left"><p>30 (14f/16&#x000a0;m)</p><p>10%</p></td></tr><tr><td align="left">50&#x02013;59</td><td align="left"><p>31 (11f/20&#x000a0;m)</p><p>22.96%</p></td><td align="left"><p>6 (1f/5&#x000a0;m)</p><p>6.67%</p></td><td align="left"><p>5 (1f/4&#x000a0;m)</p><p>6.02%</p></td><td align="left"><p>42 (13f/29&#x000a0;m)</p><p>14%</p></td></tr><tr><td align="left">60&#x02013;69</td><td align="left"><p>38 (14f/24&#x000a0;m)</p><p>28.15%</p></td><td align="left"><p>37 (11f/26&#x000a0;m)</p><p>41.11%</p></td><td align="left"><p>17 (9f/8&#x000a0;m)</p><p>20.49%</p></td><td align="left"><p>92 (34f/58&#x000a0;m)</p><p>30%</p></td></tr><tr><td align="left">70&#x02013;79</td><td align="left"><p>19 (7f/12&#x000a0;m)</p><p>14.07%</p></td><td align="left"><p>28 (12f/16&#x000a0;m)</p><p>31.11%</p></td><td align="left"><p>35 (17f/18&#x000a0;m)</p><p>42.17%</p></td><td align="left"><p>82 (36f/46&#x000a0;m)</p><p>27%</p></td></tr><tr><td align="left">80&#x02013;89</td><td align="left"><p>5 (1f/4&#x000a0;m)</p><p>3.70%</p></td><td align="left"><p>14 (7f/7&#x000a0;m)</p><p>15.56%</p></td><td align="left"><p>21 (8f/13&#x000a0;m)</p><p>25.30%</p></td><td align="left"><p>40 (16f/24&#x000a0;m)</p><p>12%</p></td></tr><tr><td align="left">90&#x02013;100</td><td align="left"><p>1 (0f/1&#x000a0;m)</p><p>0.74%</p></td><td align="left"><p>1 (0f/1&#x000a0;m)</p><p>1.11%</p></td><td align="left"><p>5 (1f/4&#x000a0;m)</p><p>6.02%</p></td><td align="left"><p>7 (1f/6&#x000a0;m)</p><p>2%</p></td></tr><tr><td align="left"/><td align="left"><p><bold>135 (50f/85&#x000a0;m)</bold></p><p><bold>44%</bold></p></td><td align="left"><p><bold>90 (34f/56&#x000a0;m)</bold></p><p><bold>29%</bold></p></td><td align="left"><p><bold>83 (36f/47&#x000a0;m)</bold></p><p><bold>27%</bold></p></td><td align="left"><p><bold>308 (120f/188&#x000a0;m)</bold></p><p><bold>100%</bold></p></td></tr><tr><td align="left">Mean age in years (SD)</td><td align="left">57.4 (13.4)</td><td align="left">69.9 (10.2)</td><td align="left">75.3 (8.8)</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>Total values for each column appear in bold</p><p>For each age group, the respective number of individuals in NFT stages I, II and III is presented. Frequency according to decades, including ratio between females (<bold>f</bold>, <italic>n</italic>&#x02009;=&#x02009;120) and males (<bold>m</bold>, <italic>n</italic>&#x02009;=&#x02009;188); percentages in NFT stages I to III reach within each stage a cumulative percentage of 100%; percentage in total column within entire sample; age in years</p><p><italic>SD</italic> standard deviation</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Abnormal intraneuronal tau deposits in the absence of amyloid-&#x003b2; in <italic>N</italic>&#x02009;=&#x02009;308 autopsy cases according to decades (ages of cohort 28&#x02013;100&#x000a0;years). The distribution of age groups is shown within each NFT subgroup (stages I&#x02013;III). Columns in (<bold>a</bold>&#x02013;<bold>c</bold>) display the frequency of cases in relation to the total number of cases in the respective stage. The graphs show the prevalences of AD-related non-argyrophilic AT8-positive pretangles and argyrophilic neurofibrillary changes in NFT stages I (<bold>a</bold>), II (<bold>b</bold>), and III (<bold>c</bold>). The cases show a Gaussian distribution. The mean age for cases in NFT stage I was 57.4&#x000a0;years, for NFT stage II 69.9&#x000a0;years, and for NFT III cases 75.3&#x000a0;years, i.e., the average age increased with disease progression. We computed a Monte Carlo <italic>p</italic>-value (250,000 replications) for the null hypothesis that the sample data come from a normal distribution. No significant skewness existed in either NFT class (<italic>p</italic>&#x02009;=&#x02009;0.705 for NFT I, <italic>p</italic>&#x02009;=&#x02009;0.864 for NFT II, and <italic>p</italic>&#x02009;=&#x02009;0.609 for NFT III)</p></caption><graphic xlink:href="401_2025_2862_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec4"><title>APOE genotyping</title><p id="Par10">APOE status was available for 188 of 308 (61%) cases in our study cohort and included 79 females, and 109 males; age range 28&#x02013;100. As in prior studies, the single largest group consisted of &#x003b5;3/&#x003b5;3 carriers [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. The breakdown of all carriers according to genotype, gender, and NFT stage is shown in Tables&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>a, <xref rid="Tab3" ref-type="table">2</xref>b.<table-wrap id="Tab2"><label>Table&#x000a0;2a</label><caption><p>APOE genotyping according to gender in 188/308 cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><italic>APOE</italic></th><th align="left">Female, <italic>n</italic>&#x02009;=&#x02009;79 (42.0%)</th><th align="left">Male, <italic>n</italic>&#x02009;=&#x02009;109 (58.0%)</th><th align="left">Total, 188 (100%)</th></tr></thead><tbody><tr><td align="left">&#x003b5;2/&#x003b5;2</td><td align="left">1</td><td align="left">1</td><td align="left">2</td></tr><tr><td align="left">&#x003b5;2/&#x003b5;3</td><td align="left">16</td><td align="left">23</td><td align="left">39</td></tr><tr><td align="left">&#x003b5;2/&#x003b5;4</td><td align="left">22</td><td align="left">28</td><td align="left">50</td></tr><tr><td align="left">&#x003b5;3/&#x003b5;3</td><td align="left">23</td><td align="left">40</td><td align="left">63</td></tr><tr><td align="left">&#x003b5;3/&#x003b5;4</td><td align="left">16</td><td align="left">15</td><td align="left">31</td></tr><tr><td align="left">&#x003b5;4/&#x003b5;4</td><td align="left">1</td><td align="left">2</td><td align="left">3</td></tr></tbody></table><table-wrap-foot><p>APOE &#x003b5;3/&#x003b5;3 was the most common variant in our cohort, as reported previously for the general population [<xref ref-type="bibr" rid="CR7">7</xref>]. A single APOE &#x003b5;4 allele increases the risk of developing AD two- to four-fold [<xref ref-type="bibr" rid="CR48">48</xref>], and persons with APOE &#x003b5;4/&#x003b5;4 have an eight-fold to 12-fold increased risk of doing so [<xref ref-type="bibr" rid="CR48">48</xref>]. Here, as elsewhere, APOE &#x003b5;2/&#x003b5;2 was the least common variant, and individuals with this variant or with the &#x003b5;2/&#x003b5;3 variant presumably were more resistant to AD [<xref ref-type="bibr" rid="CR48">48</xref>]</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table&#x000a0;2b</label><caption><p>APOE genotyping according to NFT/NT stage (AT8-IHC) in 188/308 cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">NFT stage</th><th align="left">&#x003b5;2/&#x003b5;2, <italic>n</italic>&#x02009;=&#x02009;2 (1.0%)</th><th align="left">&#x003b5;2/&#x003b5;3, <italic>n</italic>&#x02009;=&#x02009;39 (20.8%)</th><th align="left">&#x003b5;2/&#x003b5;4, <italic>n</italic>&#x02009;=&#x02009;50 (26.6%)</th><th align="left">&#x003b5;3/&#x003b5;3, <italic>n</italic>&#x02009;=&#x02009;63 (33.5%)</th><th align="left">&#x003b5;3/&#x003b5;4, <italic>n</italic>&#x02009;=&#x02009;31 (16.5%)</th><th align="left">&#x003b5;4/&#x003b5;4, n&#x02009;=&#x02009;3 (1.6%)</th><th align="left">Total, 188<break/> (100%)</th></tr></thead><tbody><tr><td align="left">I</td><td align="left">1 (50.0%)</td><td align="left">17 (43.6%)</td><td align="left">26 (52.0%)</td><td align="left">32 (50.8%)</td><td align="left">13 (41.9%)</td><td align="left">1 (33.3%)</td><td align="left">90 (47.9%)</td></tr><tr><td align="left">II</td><td align="left">1 (50.0%)</td><td align="left">10 (25.6%)</td><td align="left">11 (22.0%)</td><td align="left">22 (34.9%)</td><td align="left">4 (12.9%)</td><td align="left">2 (66.7%)</td><td align="left">50 (26.6%)</td></tr><tr><td align="left">III</td><td align="left"/><td align="left">12 (30.8%)</td><td align="left">13 (26.0%)</td><td align="left">9 (14.3%)</td><td align="left">14 (45.2%)</td><td align="left"/><td align="left">48 (25.5%)</td></tr></tbody></table><table-wrap-foot><p>A total of 90 (47.9%) cases were assigned to NFT stage I, 50 (26.6%) to stage II, and 48 (25.5%) to NFT stage III</p><p><italic>NFT</italic> neurofibrillary tangle, <italic>NT</italic> neuropil threads, <italic>IHC</italic> immunohistochemistry</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table&#x000a0;2c</label><caption><p>APOE genotype distribution in 188/308 cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Genotype</th><th align="left">Genotype frequency (%)</th></tr></thead><tbody><tr><td align="left">&#x003b5;2/&#x003b5;2</td><td align="left">1.06</td></tr><tr><td align="left">&#x003b5;2/&#x003b5;3</td><td align="left">20.74</td></tr><tr><td align="left">&#x003b5;2/&#x003b5;4</td><td align="left">27</td></tr><tr><td align="left">&#x003b5;3/&#x003b5;3</td><td align="left">33.51</td></tr><tr><td align="left">&#x003b5;3/&#x003b5;4</td><td align="left">16.49</td></tr><tr><td align="left">&#x003b5;4/&#x003b5;4</td><td align="left">1.6</td></tr><tr><td align="left"/><td align="left">100</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left">Genotype</th><th align="left">Number of cases</th></tr></thead><tbody><tr><td align="left">&#x003b5;2/&#x003b5;2</td><td align="left"><italic>n</italic>&#x02009;=&#x02009;2</td></tr><tr><td align="left">&#x003b5;2/&#x003b5;3</td><td align="left"><italic>n</italic>&#x02009;=&#x02009;39</td></tr><tr><td align="left">&#x003b5;2/&#x003b5;4</td><td align="left"><italic>n</italic>&#x02009;=&#x02009;50</td></tr><tr><td align="left">&#x003b5;3/&#x003b5;3</td><td align="left"><italic>n</italic>&#x02009;=&#x02009;63</td></tr><tr><td align="left">&#x003b5;3/&#x003b5;4</td><td align="left"><italic>n</italic>&#x02009;=&#x02009;31</td></tr><tr><td align="left">&#x003b5;4/&#x003b5;4</td><td align="left"><italic>n</italic>&#x02009;=&#x02009;3</td></tr><tr><td align="left"/><td align="left"><italic>n</italic>&#x02009;=&#x02009;188</td></tr></tbody></table><table-wrap-foot><p>The percentages for our gentotypes &#x003b5;2/&#x003b5;2 (1.06%) and &#x003b5;4/&#x003b5;4 (1.6%) approximated those in the general population. The &#x003b5;2/&#x003b5;3 (20.74%) and &#x003b5;2/&#x003b5;4 (27%) genotype frequencies were elevated (overrepresented)</p></table-wrap-foot></table-wrap><table-wrap id="Tab5"><label>Table&#x000a0;2d</label><caption><p>Allele frequencies in 188/308 cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Allele</th><th align="left">Allele frequency (%)</th></tr></thead><tbody><tr><td align="left">&#x003b5;2</td><td char="." align="char">24.7</td></tr><tr><td align="left">&#x003b5;3</td><td char="." align="char">52.1</td></tr><tr><td align="left">&#x003b5;4</td><td char="." align="char">23.1</td></tr></tbody></table><table-wrap-foot><p>The allele frequencies for <bold>&#x003b5;</bold>2 and &#x003b5;4 were elevated (overrepresented); the &#x003b5;3 frequency was low (underrepresented): The &#x003b5;2 allele frequency was 24.7% instead of 8% in the general population. The &#x003b5;4 allele frequency was 23.1% instead of 14% in the general population (although not, as in AD, ca. 30&#x02013;40%). The &#x003b5;3 frequency was 52.1% instead of 78% in the general population</p></table-wrap-foot></table-wrap><table-wrap id="Tab6"><label>Table&#x000a0;2e</label><caption><p>Allele frequencies in 188/308 cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2">Genotype Mean age (yrs)</th></tr></thead><tbody><tr><td align="left">&#x003b5;2/&#x003b5;2</td><td char="." align="char">60</td></tr><tr><td align="left">&#x003b5;2/&#x003b5;3</td><td char="." align="char">65.07</td></tr><tr><td align="left">&#x003b5;2/&#x003b5;4</td><td char="." align="char">66.12</td></tr><tr><td align="left">&#x003b5;3/&#x003b5;3</td><td char="." align="char">64.93</td></tr><tr><td align="left">&#x003b5;3/&#x003b5;4</td><td char="." align="char">64.93</td></tr><tr><td align="left">&#x003b5;4/&#x003b5;4</td><td char="." align="char">61.33</td></tr></tbody></table><table-wrap-foot><p>The mean ages for the various APOE genotypes hardly differed. In addition, when the cases were divided into those with and those without an &#x003b5;4 allele, the mean age in both groups did not differ: 65.5&#x000a0;years of age (SD 12.8) for those with the &#x003b5;4 allele versus 65&#x000a0;years of age (SD 15.3) for those without. A difference of 0.5&#x000a0;years exists, and the associated t-test result failed to reach significance (<italic>p</italic>&#x02009;=&#x02009;0.810)</p><p><italic>yrs</italic> years, <italic>SD</italic> standard deviation</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>Genetic analysis</title><p id="Par12">APOE genotyping was performed on archival formaldehyde-fixed brain samples (pons, cerebellum). The tissue was fixed for up to a month in an aqueous solution of formaldehyde. The QIAamp DNA Mini Kit (Qiagen, catalogue no. 51306, Hilden, Germany) and Taq PCR Master Mix Kit (Qiagen, catalogue no. 201443, Hilden, Germany) were used according to the manufacturer&#x02019;s instructions. DNA amplification for all PCR products was evaluated by 3% agarose gel electrophoresis. Aliquots of the PCR-amplified products were digested with restriction enzyme <italic>AlfIII</italic> (New England BioLabs R0541S, Ipswich, MA; 10U/&#x000b5;l), <italic>HaeII</italic> (New England BioLabs R0107S; 20U/&#x000b5;l), and <italic>HaeI</italic> (New England BioLabs R0139S; 20U/&#x000b5;l). Incubation took place at 37&#x000a0;&#x000b0;C for 3&#x000a0;h, heat inactivation at 80&#x000a0;&#x000b0;C for 20&#x000a0;min. For genotype analysis, the small fragment-sized cleavage products of <italic>AlfIII</italic>, <italic>HaeII</italic>, and <italic>HaeI</italic> were electrophoresed through 18% polyacrylamide gels stained with ethidium bromide and visualized with ultraviolet illumination.</p></sec><sec id="Sec6"><title>Tissue fixation, embedding, and sectioning</title><p id="Par13">Brain tissue was fixed by immersion in a 4% buffered aqueous solution of formaldehyde for ca. 10&#x02013;20&#x000a0;days prior to dissection and neuropathological assessment. As described previously [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR26">26</xref>], three transversally cut tissue blocks required for neuropathological diagnosis and evaluation of NFT stages of AD-related changes were excised: The first block was dissected at the mid-uncal level through medial portions of the temporal lobe and encompassed anterior portions of the hippocampal formation and the parahippocampal gyrus (entorhinal and transentorhinal regions), including the occipitotemporal gyrus and inferior temporal gyrus up to the superior temporal gyrus. The second block was cut through the temporal lobe at the level of the lateral geniculate body and included middle portions of the hippocampal formation that perfectly showed its various subdivisions. The third block was oriented perpendicular to the calcarine fissure and contained portions of the peristriate region, the parastriate and the striate areas. Some of the tissue blocks were cryosectioned, and the majority were embedded in polyethylene glycol (PEG 1000, Merck, Carl Roth Ltd, Karlsruhe, Germany) and sectioned at a thickness of 100&#x000a0;&#x000b5;m on a tetrander microtome (Jung, Heidelberg, Germany), as described previously [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Compared to routine paraffin-embedded sections of 4&#x02013;5&#x000a0;&#x000b5;m or cryosections of 5&#x02013;15&#x000a0;&#x000b5;m thickness, this unconventional section thickness permits the optical superimposition of biological structures, including pretangles, NFT/NT, and A&#x003b2; deposits, and nerve cells with their dendritic arborizations, as well as large portions of the arborization around each involved neuron [<xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec7"><title>Staining and immunocytochemistry</title><p id="Par14">One set of free-floating sections from each case was processed according to an updated and simplified protocol for staining with aldehyde fuchsine to visualize the pigmentation properties of the different nerve cell populations in the adult human brain, as well as intraneuronal and extraneuronal lipofuscin pigment deposits; counterstaining with Darrow red was performed to visualize basophilic material in nerve cells [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Aldehyde fuchsine also visualizes cortical microinfarctions and CD86-immunopositive macrophages in brain tissue [<xref ref-type="bibr" rid="CR28">28</xref>]. Silver methods (Campbell-Switzer, Gallyas silver staining) as well as 4G8 immunohistochemistry were used here to visualize A&#x003b2; deposits and argyrophilic neurofibrillary lesions [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR67">67</xref>].</p><p id="Par15">For immunohistochemistry, sets of free-floating sections were treated for 30&#x000a0;min in a mixture of 1 part methanol plus 1 part 30% H<sub>2</sub>O<sub>2</sub> and 8 parts 80% Tris. Following pretreatment with 100% formic acid for 3&#x000a0;min to facilitate the immunoreactions, blocking with bovine serum albumin was performed to inhibit endogenous peroxidase and nonspecific binding. Subsequently, each of the sets was incubated for 18&#x000a0;h at 20&#x000a0;&#x000b0;C using the following commercially available primary antibodies: (<bold>1</bold>) a monoclonal anti-PHF-Tau antibody (1:2000; Clone AT8; Pierce Biotechnology, Rockford, IL, USA [Thermo Scientific]) for detection of abnormal tau protein in both pretangles and mature neurofibrillary changes of the Alzheimer-type. AT8 recognizes a phosphate-dependent epitope at Serine 202, Threonin 205, and possibly Serine 208 of the tau protein [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR87">87</xref>] or (<bold>2</bold>) a monoclonal mouse antibody anti-beta-amyloid (1:5000; 1&#x000a0;mg/mL; Clone 4G8; Covance, Dedham, MA, USA) for A&#x003b2;. After processing with a corresponding secondary biotinylated antibody (anti-mouse or anti-rabbit IgG, 1:200; Linaris, Vector Laboratories, Burlingame, CA, USA) for 1.5&#x000a0;h, all immunoreactions were visualized with the avidin&#x02013;biotin complex (ABC, Vectastain, Vector Laboratories, Burlingame, CA, USA) for 2&#x000a0;h and the chromogen 3,3&#x02019;-diaminobenzidine tetrahydrochloride (DAB, D5637 Sigma, Taufkirchen, Germany). Omission of the primary antiserum resulted in non-staining. Positive as well as negative control sections were included.</p><p id="Par16">The tissue sections were cleared and mounted in a synthetic resin with a refraction index of 1.58 (Histomount, National Diagnostics, Atlanta, GA, USA). Sections were viewed with a BX61 microscope (Olympus Optical, Tokyo, Japan), and digital micrographs were taken by H.B. using an Olympus XC50 camera together with the extended focal imaging (EFI) function (Cell D Imaging Software, Olympus, M&#x000fc;nster, Germany). The EFI function was used for stacks of images taken at different optical planes. The algorithm extracts the image features with the sharpest contrast from all layers of the stack and merges them into a single image. Tau pathology and nerve cell loss were assessed semiquantitatively in all selected regions of all 308 cases by two observers (HB, MS) as follows: 0 (none/no detectable tau pathology), 0.5 (sparse or isolated changes), 1 (mild), 2 (moderate), 3 (severe changes). Neuronal loss in each region was determined based on the presence of extraneuronal lipofuscin granules and pigment-containing microglia as markers of lost pigment-laden nerve cells.</p></sec><sec id="Sec8"><title>Immunofluorescence (SYP&#x02009;+&#x02009;AT8, MAP2&#x02009;+&#x02009;AT8) and confocal imaging</title><p id="Par17">Fixed tissue from the hippocampal formation, including the entorhinal and transentorhinal regions, was sectioned at 100&#x000a0;&#x000b5;m on a vibratome (VT1200S vibratome, Leica, Wetzlar, Germany). The sections were then washed 1&#x02009;&#x000d7;&#x02009;in PBS (Thermo Fisher Scientific, Waltham, MA, USA) and exposed to heat retrieval with 0.1&#x000a0;M citrate buffer (pH 6.0, 10&#x000a0;min, 100&#x000a0;&#x000b0;C). They then were incubated for 3&#x000a0;h in a blocking buffer at room temperature (3% BSA, Bio Froxx, Einhausen, Germany; 0.3% Triton X-100, Roche, Mannheim, Germany). Immunolabeling was performed for 1 d in a blocking buffer at 4&#x000a0;&#x000b0;C. The following antibodies were used: (<bold>1</bold>) a polyclonal chicken microtubule-associated protein MAP2A/B antibody (1:500, EnCor Biotechnology, Gainesville, FL, USA) as a dendritic marker; (<bold>2</bold>) a guinea pig polyclonal SYP antibody (1:500, Synaptic Systems, G&#x000f6;ttingen, Germany) that recognizes presynaptic vesicles; (<bold>3</bold>) AT8 (1:500, see above). Subsequently, all sections were rinsed three times for 30&#x000a0;min 1&#x02009;&#x000d7;&#x02009;in PBS. Incubation in blocking buffer with secondary antibody was performed with Alexa Fluor conjugated antibodies 488 (RRID:AB_2341099 for AT8), 647 (RRID:AB_2340379 for MAP2) and 647 (RRID:AB_2340476 for SYP) from Jackson ImmunoResearch Laboratories, Ely, UK, diluted 1:200 at room temperature for 2&#x000a0;h. The sections were subsequently rinsed again three times for 30&#x000a0;min. All steps from blocking onwards were performed under gentle agitation. The sections were mounted on slides with ProLong Gold antifade mountant (Invitrogen, Waltham, MA, USA). Confocal microscopy was performed by M.S. with Leica SP8 (for Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) or SPE (for Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>) microscopes (Leica, Wetzler, Germany) as a three-dimensional image (finally shown as a projection image) with a 40&#x02009;&#x000d7;&#x02009;objective (HC PL APO CS2 NA 1.30 for SP8 and ACS APO NA 1.50 for SPE, both oil immersion), pinhole aperture&#x02009;=&#x02009;65.2&#x000a0;&#x000b5;m for SP8 and 98.5&#x000a0;&#x000b5;m for SPE. The images were then deconvolved using Huygens software (Scientific Volume Imaging, Hilversum, The Netherlands) and further processing of the images with adjustment of brightness and contrast in Imaris software (Oxford Instruments, Abingdon, UK).</p></sec><sec id="Sec9"><title>Statistical analyses</title><p id="Par18">Descriptive statistics are presented as frequencies in the case of categorial variables; otherwise, the median and range are displayed. Chi-square, Mann&#x02013;Whitney <italic>U</italic>, and Kruskall-Wallis tests were used to analyze between-group comparisons of categorical or ordered/metric variables. A two-sided, explorative type 1 error of 5% was assumed for all analyses. All analyses were conducted using the R software for statistical computing (version 4.3.2, <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">www.r-project.org</ext-link>).</p></sec></sec><sec id="Sec10"><title>Results</title><sec id="Sec11"><title>Development of a plexus of abnormal tau-containing axon terminals mingled with similarly involved distal dendritic segments in the transentorhinal and entorhinal regions surrounding layer pre-&#x003b1; projection cells</title><p id="Par19">Within the cerebral cortex, abnormal tau initially occurred in the transentorhinal or entorhinal regions only as AT8-positive dot-like (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) and AT8-positive bent dendritic segments in the molecular layer and layer pre-&#x003b1; (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). The AT8-immunopositive dendritic segments appeared to surround an individual (single) pyramidal cell (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a&#x02013;c) rather than to originate from multiple overlapping pyramidal cells. A skirt-like arrangement of bent distal segments of the dendrites permitted recognition of a central AT8-immunonegative area, around which the skirt of immunopositive distal dendritic segments was radially oriented.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Immunofluorescence and AT8-positive dot-like structures. The first traces of abnormal tau in the cerebral cortex consistently occurred in anteromedial portions of the temporal lobe. <bold>a</bold>, <bold>b</bold> These consisted of a few AT8-immunopositive dot-like structures amidst many synaptophysin-positive terminal axonal boutons. <bold>a</bold> Molecular layer of the entorhinal cortex close to the transition to the transentorhinal cortex. Presynapses are immunolabeled against SYP1 (<italic>red</italic>). AT8 (<italic>green</italic>) marks abnormal tau. <italic>Framed area</italic> is shown at higher magnification in (<bold>b</bold>). <bold>b</bold> The AT8-immunopositive presynapse (dot-like structure is shown as a merge of the channels (upper one-third) and in the single channel representations (lower two-thirds). 100&#x000a0;&#x000b5;m section, male 73&#x000a0;years of age, NFT I, APOE unavailable</p></caption><graphic xlink:href="401_2025_2862_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Involvement of layer pre-&#x003b1; in the entorhinal region in AT8 immunoreactions. <bold>a</bold>, <bold>b</bold> Shortly after the appearance of the dot-like particles, bent dendritic segments surrounding pre-&#x003b1; cells (lower left) in a skirt-like pattern were seen. Note swelling of the dendritic segments in (<bold>b</bold>)<bold>.</bold> Framed area in (<bold>a</bold>) is shown in greater detail in (<bold>b</bold>). Despite the absence of visible physical contacts between the center and the &#x02018;skirt&#x02019; of AT8-immunoreactive dendrites at the perimeter, the impression emerges that they are not bundles of neuronal processes randomly belonging to multiple pyramidal cells. It can be assumed that the cell soma, to which the dendrites in (<bold>c</bold>) belong, is located in the center of the micrograph but is still free of abnormal tau. 100&#x000a0;&#x000b5;m section, male 45&#x000a0;years of age, NFT stage I, &#x003b5;3/&#x003b5;3. <bold>c</bold>, <bold>d</bold> In addition to the AT8-immunopositive dot-like structures, the distal dendritic processes filled with pretangle tau were among the first components in cortical projection cells to become involved. The distal dendritic processes increased in diameter and followed a curved course (<bold>c</bold>). Abnormal tau then extended into the proximal dendrites and marked a small portion of the soma (<bold>d</bold>). 100&#x000a0;&#x000b5;m sections, female 52&#x000a0;years of age, NFT I, &#x003b5;3/&#x003b5;4 (<bold>c</bold>) and male 77&#x000a0;years of age, NFT II, APOE unavailable (<bold>d</bold>).<bold> e</bold>, <bold>f</bold> Abnormal tau then marked the dendrites (arrow<italic>s</italic> in <bold>f</bold>) and the cell soma. Finally, pretangle tau also appeared in the axon (<bold>f</bold>) and could then be seen in the perforant path (see Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). <italic>Framed area</italic> in <bold>e</bold> is shown in greater detail in (<bold>f</bold>). 100&#x000a0;&#x000b5;m section, same individual as in (<bold>a</bold>, <bold>b</bold>). Scale bar in <bold>a</bold> applies to <bold>c</bold>, bar in <bold>b</bold> is valid for <bold>c</bold>, <bold>d</bold>, and <bold>f</bold></p></caption><graphic xlink:href="401_2025_2862_Fig4_HTML" id="MO5"/></fig></p><p id="Par20">The AT8-positive distalmost dendrites displayed local varicose enlargements and constrictions [<xref ref-type="bibr" rid="CR11">11</xref>] (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a, b). Once concomitant alterations were present in nearly all of the distal dendrites generated from a single pre-&#x003b1; cell (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c), traces of abnormal tau in the proximal dendrites were seen (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>d) that then filled the cell soma and, finally, even the axon (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>e, f). These abnormalities in individual nerve cells developed near closely adjacent cells of the same type that were devoid of abnormal tau.</p><p id="Par21">The pretangle tau in dendrites gradually became fibrillar neuropil threads (NTs). After the death of the host neuron, these dendritic processes lost their ensheathing cellular membrane and persisted, in analogy to ghost tangles, as &#x02018;ghost threads&#x02019; (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). The tau inclusions in the cell somata converted into flame- or star-shaped NFTs (Suppl. Fig.&#x000a0;2). Tangle-bearing nerve cells can survive for a long time but ultimately die [<xref ref-type="bibr" rid="CR93">93</xref>]. The NFTs then developed into ghost tangles, and the neuronal lipofuscin granules from the dead cells lay exposed temporarily in the extracellular space (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a, b), where they were phagocytosed by microglia (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>c&#x02013;f). The gradual progress of neuronal loss (based on the presence of extraneuronal lipofuscin granules and pigment-containing microglia as markers of lost pigment-laden nerve cells) could be similarly followed in other regions affected during the AD-related pathological process (Suppl. Fig.&#x000a0;3).<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Immunofluorescence and AT8-immunopositive &#x02018;ghost threads&#x02019;.<bold> a</bold> Overview of the molecular layer in the entorhinal region. Neuronal cell somata and dendrites are immunolabeled in <italic>red</italic> (MAP2). AT8 (<italic>green</italic>) marks abnormal tau. Framed areas are shown at higher magnification in (<bold>b</bold>&#x02013;<bold>d</bold>). <italic>White arrows</italic> indicate MAP2-immunopositive neurites shown as a merge of the two immunolables in <bold>a</bold> and in the single channels (<bold>b</bold>&#x02013;<bold>d</bold>), whereas <italic>white asterisks</italic> mark MAP2-immunonegative &#x02018;ghost threads&#x02019; in the neuropil (no overlap with the MAP2 signal in the merge). Ghost threads have not been described previously. 100&#x000a0;&#x000b5;m section, female 73&#x000a0;years of age, NFT III, &#x003b5;2/&#x003b5;4</p></caption><graphic xlink:href="401_2025_2862_Fig5_HTML" id="MO4"/></fig><fig id="Fig6"><label>Fig.&#x000a0;6</label><caption><p>Tau-related loss of nerve cells in staining with aldehyde fuchsine and Darrow red. AD-related loss of nerve cells as indicated by aldehyde fuchsine-positive lipofuscin granules from dead pigment-laden neurons cells. <bold>a</bold> Overview of the deep terminal portion of layer pre-&#x003b1; in the lateral transentorhinal region showing the strongly pigmented pyramidal cells of this layer at mid-cortical level. Framed area is shown in greater detail in <bold>b</bold>. <bold>b</bold> This layer shows the first signs of AD-specific nerve cell loss, here indicated by extraneuronal accumulations of neuronal lipofuscin remnants in the neuropil (arrows). 100&#x000a0;&#x000b5;m section, male 72&#x000a0;years of age, NFT stage III, &#x003b5;3/&#x003b5;4. <bold>c</bold> Overview of the transentorhinal region. <italic>Framed area</italic> is displayed at higher magnification in <bold>d</bold>, and framed area in <bold>d</bold> at higher magnification in <bold>e</bold>. <bold>e</bold>, <bold>f</bold> Lipofuscin granules can be taken up by microglial cells. <italic>Arrows</italic> point to a microglial cell containing lipofuscin granules from nearby dead pyramidal cell(s). 100&#x000a0;&#x000b5;m section, male 68&#x000a0;years of age, NFT III, APOE unavailable. Scale bar in <bold>a</bold> applies to <bold>c</bold>, bar in <bold>b</bold> to <bold>e</bold></p></caption><graphic xlink:href="401_2025_2862_Fig6_HTML" id="MO6"/></fig></p><p id="Par22">Involved axons of the projection cells in the outer entorhinal layers forming the perforant path beneath the subiculum and heading for the hippocampal formation ran parallel to each other, these axons characteristically contained pretangle tau for short distances, interrupted by longer gaps lacking abnormal tau [<xref ref-type="bibr" rid="CR123">123</xref>] (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>a, b). Between bundles of abnormal axons of the perforant path lay disseminated a few pretangle-containing interneurons with very long, smoothly contoured dendrites oriented at nearly 90 degrees to the fibers of the perforant path in the white matter subjacent to the subiculum (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>c, d). These interneurons were consistently found at this location (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>e, f).<fig id="Fig7"><label>Fig.&#x000a0;7</label><caption><p>Abnormal tau in perforant path axons and interneurons in AT8 immunoreactions. <bold>a</bold>, <bold>b</bold> The perforant path in the white matter subjacent to the subiculum. <italic>Framed areas</italic> in <bold>a</bold>, <bold>c</bold> (axons) are shown in greater detail in <bold>b</bold>, <bold>d</bold>. At this location, a few AT8-positive interneurons regularly occurred (two are shown in <bold>b</bold> and <bold>c</bold>, one in <bold>e</bold> and<bold> f</bold>) and were characterized by very long, unbranched and smoothly contoured dendrites; <bold>e</bold> is shown in <bold>f</bold> at higher magnification. The dendrites were oriented at right angles to the course of the AT8-positive axons. 100&#x000a0;&#x000b5;m sections, male 78&#x000a0;years of age, NFT stage III, &#x003b5;3/&#x003b5;4 (<bold>a</bold>, <bold>b</bold>); female 73&#x000a0;years of age, NFT stage III, APOE unavailable; (<bold>c</bold>, <bold>d</bold>); male 71&#x000a0;years of age, NFT stage III, &#x003b5;3/&#x003b5;4 (<bold>e</bold>, <bold>f</bold>). AT8 immunoreactions. Scale bar in <bold>b</bold> is valid for <bold>e</bold>, bar in <bold>f</bold> also applies to <bold>c</bold></p></caption><graphic xlink:href="401_2025_2862_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec12"><title>Development of a plexus of abnormal terminal axons and distal dendrites surrounding pyramidal cells of the prosubiculum, bifurcating into both the stratum oriens and stratum lacunosum of CA1 and CA2</title><p id="Par23">AT8-positive axons of the perforant path accumulated in the prosubiculum and, from there, axon collaterals bifurcated into two stripe-like plexus, one within the CA1 and CA2 stratum oriens, the other, less dense, in the CA1 and CA2 stratum lacunosum without wide extensions into their molecular layer (Tables <xref rid="Tab7" ref-type="table">3</xref> and <xref rid="Tab8" ref-type="table">4</xref>, Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>). The conspicuous AT8-positive plexus within the stratum oriens displayed a relatively sharp border to the alveus but gradually decreased in density towards the pyramidal layer. At the border between CA1 and CA2, the two stripes once again approximated each other and formed, together with the pyramidal layer of CA2, a broad zone of AT8-positive cellular processes (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>).<fig id="Fig8"><label>Fig.&#x000a0;8</label><caption><p>Overview of the human Ammon&#x02019;s horn (CA1-CA4) and the dentate fascia (Fd) in an AT8-immunoreaction. The figure displays the two stripes of accumulated affected nerve cells processes in the stratum oriens and stratum lacunosum of CA1 (or, lac). In CA2, the stripes in the stratum oriens and stratum lacunosum approximate each other. There is neither a stratum lucidum nor a clearly recognizable stratum radiatum in CA2. The pathological process has sufficiently progressed to show the essential formations of early AD-related lesions, including not only the affected projection neurons filled with pretangle tau and/or NFTs/NTs but also the diseased axon terminal boutons and affected distal dendritic segments in the stratum oriens and stratum lacunosum of CA1 and CA2 as well as in the outer two-thirds of the dentate molecular layer. The pyramidal layer of CA1 shows numerous AT8-positive pyramidal cells. The myelin-rich alveus and the stratum radiatum display only sparse immunoreactions (al, rad). The broad molecular layer between stratum lacunosum and the obliterated hippocampal fissure (mol) similarly is poor in AT8-positive structures except for the pathological enlargements of the terminal apical dendrite of CA1 pyramidal cells. In addition, the terminal zone of the perforant path in the middle and outer two-thirds of the dentate molecular layer is marked by an abundance of immunopositive axons (mo). The granular layer and the inner third of the molecular layer of the dentate fascia are only sparsely affected (gr). Involved cells in CA2 are more densely packed than in CA1 and, here, formed a CA2 focus. The CA4 sector shows only a few affected multipolar mossy cells. 100&#x000a0;&#x000b5;m, AT8 immunoreaction, male 72&#x000a0;years of age, NFT stage III, &#x003b5;3/&#x003b5;4</p></caption><graphic xlink:href="401_2025_2862_Fig8_HTML" id="MO8"/></fig></p><p id="Par24">As in the transentorhinal/entorhinal regions, the first traces of abnormal tau in the Ammon&#x02019;s horn were seen in the CA1 stratum oriens in the form of dot-like AT8-positive axonal terminal boutons (not shown). We postulated that the dot-like structures represent collateral branches of the perforant path that contribute to the formation of the stratum oriens. These changes in CA1 were followed by the development of pretangles in all distal segments of both basal dendrites (stratum oriens) and side-branches (stratum lacunosum) of the apical dendrite of pyramidal cells (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>a, b) that formed the two stripe-like plexuses (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>). Proximal dendrites and then the cell somata of involved cells became filled with abnormal tau that developed into fibrillar NTs/NFTs (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>b). Finally, the axons of the involved CA1 cells became AT8-positive and appeared as part of the myelin-rich alveus and, lastly, the fornix (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>c and see also Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>).<fig id="Fig9"><label>Fig.&#x000a0;9</label><caption><p>AT8-positive pyramidal cells (CA1, stratum oriens) and AT8-positive spindles in the stratum moleculare of CA1. <bold>a</bold>, <bold>b</bold> Pretangles developed in basal dendrites (stratum oriens) and side branches (stratum lacunosum) of the apical dendrite of CA1 pyramidal cells. They then filled the somatodendritic domain of terminal segments of the basal dendrites of CA1 pyramidal cells. <italic>Framed are</italic> in <bold>a</bold> is shown in greater detail in (<bold>b</bold>) 100&#x000a0;&#x000b5;m section, male 57&#x000a0;years of age, NFT stage II, &#x003b5;3/&#x003b5;3. <bold>c</bold> Finally, axons of the affected cells were filled and appeared as short, thin lines in the myelin-rich alveus (and, ultimately, the fornix; not shown). 100&#x000a0;&#x000b5;m section, male 69&#x000a0;years of age, NFT stage III, APOE unavailable. <bold>d</bold>, <bold>e</bold> The distal apical dendrite of CA1 pyramidal cells developed AT8-positive spindle-shaped varicosities during the early disease phase. <italic>Framed area</italic> in <bold>d</bold> appears at higher magnification in <bold>e</bold>. 100&#x000a0;&#x000b5;m section, male 78&#x000a0;years of age, NFT III, &#x003b5;3/&#x003b5;4. <italic>Scale bar</italic> in <bold>b</bold> is valid for <bold>c</bold> and <bold>e</bold></p></caption><graphic xlink:href="401_2025_2862_Fig9_HTML" id="MO9"/></fig></p><p id="Par25">A unique feature of affected CA1 pyramidal cells during AD is that some developed AT8-positive spindle-shaped varicosities and constrictions within their distalmost apical dendrites in the stratum moleculare [<xref ref-type="bibr" rid="CR10">10</xref>] (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>d, e). These deformed segments (a sizeable portion of the apical dendrite) finally lost their connection to the host cell soma.</p><p id="Par26">As reported elsewhere [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, see also <xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR71">71</xref>], the development of pretangle tau in CA2 pyramidal cells differed from that in CA1: A thin but marked perinuclear rim of abnormal tau developed in CA2 pyramidal cells, a feature that helps to distinguish between pyramidal cells of CA1 and CA2 (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>b&#x02013;d). The soluble pretangles were uniformly distributed throughout the somatodendritic domain; however, in CA2 some pyramidal cells also displayed compressed &#x02018;packets&#x02019; of abnormal tau with rounded contours (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>c, d).<fig id="Fig10"><label>Fig.&#x000a0;10</label><caption><p>AT8 immunoreactivity in Cornu Ammonis cells. <bold>a CA1</bold> ghost tangle (an extraneuronal NFT) marks the location of a lost pyramidal cell, male 93&#x000a0;years of age, NFT III, &#x003b5;3/&#x003b5;3. <bold>b&#x02013;e CA2 pyramidal cells.</bold> CA2 cell (at left) with an AT8-positive perinuclear rim, female 93&#x000a0;years of age, NFT III, &#x003b5;3/&#x003b5;3. <bold>c</bold> CA2 cell with perinuclear rim plus aggregated tau &#x02018;packet&#x02019;, female 69&#x000a0;years of age, NFT II, APOE unavailable. <bold>d</bold> CA2 cell with perinuclear rim and tau &#x02018;packet&#x02019;, female 77&#x000a0;years of age, NFT II, &#x003b5;3/&#x003b5;4. <bold>e</bold> CA2 cell with a globose tangle, male 92&#x000a0;years of age, NFT III, APOE unavailable. Globose tangles occur in CA2-CA4 and in the granular cells of the Fd, but not in CA1. The perinuclear rim possibly influenced the consolidation of pretangle tau into a globose tangle close to the cell nucleus. <bold>f</bold>&#x02013;<bold>k</bold> CA3/CA4 multipolar mossy cells. <bold>f</bold> CA4 excrescence-bearing mossy cell, female 52&#x000a0;years of age, NFT I, &#x003b5;3/&#x003b5;4. <bold>g</bold> CA3 mossy cell with excrescences, male 75&#x000a0;years of age, NFT III, &#x003b5;2/&#x003b5;4. <bold>h</bold> CA4 mossy cell with excrescences and axonal tau, male 62&#x000a0;years of age, NFT I, &#x003b5;3/&#x003b5;3. <bold>i</bold> CA4 mossy cell with perinuclear rim plus excrescences, male 75&#x000a0;years of age, NFT III, &#x003b5;2/&#x003b5;4e. Same individual as in <bold>g</bold>. <bold>k</bold> CA4 mossy cell with perinuclear rim and tau &#x02018;packet&#x02019;, male 93&#x000a0;years of age, NFT III, APOE &#x003b5;3/&#x003b5;3. Same individual as in <bold>a</bold>. <bold>m</bold> Fd cell with an AT8-positive perinuclear rim, male 57&#x000a0;years of age, NFT III, &#x003b5;3/&#x003b5;3. 100&#x000a0;&#x000b5;m sections. AT8 immunoreactions. The micrographs for <bold>b</bold>, <bold>d</bold>, <bold>g</bold>, and <bold>i</bold> were taken by M.S. using a Keyence BZ-X800 series microscope (Keyence Deutschland Inc., Neu-Isenburg, Germany) to acquire z-stack images together with the Keyence Analyzer software Full Focus. The Full Focus function was used to remove out-of-focus image points and generate a projection image of all focus points. Scale bar in <bold>a</bold> is valid for <bold>b</bold>&#x02013;<bold>k</bold></p></caption><graphic xlink:href="401_2025_2862_Fig10_HTML" id="MO10"/></fig></p></sec><sec id="Sec13"><title>Occurrence of pretangle tau in thorny excrescences of CA3 and CA4 projection cells</title><p id="Par27">The CA3 sector contained reduced numbers of abnormal tau-containing neuronal processes in the stripe-like zones below and above the pyramidal layer. The stripes were replaced by pretangles in the thorny excrescences (spines) along the proximal dendrites of CA3 and CA4 mossy cells [<xref ref-type="bibr" rid="CR9">9</xref>] (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>f&#x02013;i). All excrescences of one and the same nerve cells appeared to become AT8-positive simultaneously (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>f&#x02013;i). Assemblies of involved excrescences were also observable in isolation [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par28">The pretangle tau filled the dendrites and gradually tapered off distally, again followed by changes in the cell somata and finally the axon. The occurrence of involved pyramidal cells in the prosubiculum and CA1/CA2 sectors consistently preceded the occurrence of tau inclusions in the CA3/CA4 sectors (Tables <xref rid="Tab7" ref-type="table">3</xref> and <xref rid="Tab8" ref-type="table">4</xref>). Again, a perinuclear rim of pretangle tau was present in CA3/CA4 mossy cells [<xref ref-type="bibr" rid="CR86">86</xref>] (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>h&#x02013;k). With time, the soluble pretangles were no longer visible in the dendrites and probably converted to fibrillar tau nearby the cell nucleus to form a globose tangle. We did not see ghost tangles in CA3/CA4 sectors during NFT stages I&#x02013;III. Sector CA4 contained, in addition to the predominating mossy cells, a few AT8-positive and lipofuscin-rich cells (interneurons) that had lengthy and smoothly contoured dendrites. These cells displayed neither AT8-immunoreactive perinuclear rims nor thorny excrescences.<table-wrap id="Tab7"><label>Table&#x000a0;3</label><caption><p>Eight involved anatomical regions in cases with early (NFT stages I&#x02013;III) tau changes</p></caption><graphic position="anchor" xlink:href="401_2025_2862_Tab3_HTML" id="MO14"/><table-wrap-foot><p>The density of all AT8-positive lesions (pretangle tau, NFTs, NTs) taken together was semiquantitatively assessed as 0&#x02009;=&#x02009;none, 0.5&#x02009;=&#x02009;subtle, 1.0&#x02009;=&#x02009;mild, 2.0&#x02009;=&#x02009;marked, and 3.0&#x02009;=&#x02009;severe. Statistics are given as median (bold type, 0&#x02009;=&#x02009;<italic>white</italic>, 0.5&#x02009;=&#x02009;<italic>pink</italic>, 1&#x02009;=&#x02009;<italic>dark pink</italic>, 2&#x02009;=&#x02009;<italic>red</italic>, or 3&#x02009;=&#x02009;<italic>dark red</italic>) and percentage of cases with single tau ratings ranging from 0 to 3 (in parentheses, single ratings separated by/and adding up to 100% in each cell). Each Kruskal&#x02013;Wallis test for the eight regions shown (always comparing NFT I vs. NFT II vs. NFT III) achieved a significant <italic>p</italic>-value of&#x02009;&#x0003c;&#x02009;0.001). <italic>Black arrow</italic> at the left shows the known connectivities within the hippocampal formation; the <italic>black arrow</italic> at right indicates the sequence of pathological tau progression proposed in the present study</p><p><italic>tre</italic> transentorhinal region, <italic>ento</italic> entorhinal region, <italic>CA1-CA4</italic> cornu Ammonis (Ammon&#x02019;s horn) sectors 1&#x02013;4, <italic>Fd</italic> dentate fascia, <italic>sub</italic> subiculum</p></table-wrap-foot></table-wrap><table-wrap id="Tab8"><label>Table&#x000a0;4</label><caption><p>Layers/Structures affected in cases with early tau morphological changes according to NFT stages</p></caption><graphic position="anchor" xlink:href="401_2025_2862_Tab4_HTML" id="MO16"/><table-wrap-foot><p>The percentage of cases showing the presence of AT8-positive lesions in specific structures is given according to each NFT stage. The density of all AT8-positive inclusions taken together was semiquantitatively assesed as 0&#x02009;=&#x02009;none, 0.5&#x02009;=&#x02009;subtle, 1.0&#x02009;=&#x02009;mild, 2.0&#x02009;=&#x02009;marked, and 3.0&#x02009;=&#x02009;severe. Statistics are given as median (bold type, 0&#x02009;=&#x02009;<italic>white</italic>, 0.5&#x02009;=&#x02009;<italic>pink</italic>, 1&#x02009;=<italic>&#x02009;dark pink</italic>, 2&#x02009;=&#x02009;<italic>red</italic>, or 3&#x02009;=&#x02009;<italic>dark red</italic>; here not applicable) and percentage of patients with single tau ratings ranging from 0 to 3 (in parentheses, single ratings separated by/and adding up to 100% in each cell). The local structures with abnormal morphological changes displayed in relationship to each structure a significant difference (Kruskall-Wallis test <italic>p</italic>-value of&#x02009;&#x0003c;&#x02009;0.001) between NFT stages I, II, and III</p><p><italic>tr perforans</italic> perforant path (tractus perforans), <italic>CA1-CA3</italic> cornu Ammonis (Ammon&#x02019;s horn) sectors 1&#x02013;3, <italic>oriens</italic> stratum oriens, <italic>lacunos</italic> stratum lacunosum, <italic>Fd: outer mol</italic> dentate fascia, outer molecular layer, <italic>Fd: inner mol</italic> dentate fascia, inner molecular layer, <italic>alveus</italic> alveus hippocampus (white matter)</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec14"><title>Development of abnormal tau in granular cells of the dentate fascia</title><p id="Par29">With the development of pretangle tau in perforant path axons, a plexus of dot-like AT8-positive terminal endings developed in the middle and outer two-thirds of the dentate molecular layer [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR127">127</xref>] (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref> mo). Subsequently, a few dot-like structures also developed within the inner one-third of the molecular layer. In parallel with this late change, slender dentate granular cells developed a perinuclear rim of pretangle tau (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>m). Abnormal tau was also found evenly disseminated throughout the somatodendritic domain. Granular cells with abnormal tau were not altered in shape.</p></sec><sec id="Sec15"><title>Late-developing abnormal changes</title><p id="Par30">In the subiculum, abnormal tau was seen late (Fig.&#x000a0;<xref rid="Fig11" ref-type="fig">11</xref>). Subicular involvement peaked as the latest feature of the AD-related hippocampal process [<xref ref-type="bibr" rid="CR23">23</xref>] and was accompanied by a gradual increase of AT8-positive axons in both the alveus and the fornix (Tables <xref rid="Tab7" ref-type="table">3</xref>, <xref rid="Tab8" ref-type="table">4</xref>, Figs. <xref rid="Fig8" ref-type="fig">8</xref> alv and <xref rid="Fig11" ref-type="fig">11</xref>).<fig id="Fig11"><label>Fig.&#x000a0;11</label><caption><p>Views from the CA1 sector of the prosubiculum, subiculum and presubiculum. <bold>a</bold> The wedge-shaped prosubiculum is located between the CA1 sector and the subiculum. The hatched black line is intended to aid in distinguishing the prosubiculum from the subiculum. The subiculum appears on cross-sections as a wing-shaped structure and is dominated by large pyramidal cells furnishing output pathways from the Ammon&#x02019;s horn. <bold>b</bold> In NFT stage III, the region remains almost intact or displays only a few pyramidal cells with pretangles. Here, only AT8-positive axons are seen. Small bundles of AT8-positive axons belonging to the perforant path penetrate the subiculum and run into the prosubiculum, where they split into two stripes: a superficial and relatively thick stripe that heads to the stratum lacunosum of CA1, and a deep stripe that maintains contact to the subicular surface and heads towards the CA1 stratum oriens (above the <italic>hatched black line</italic>). In pigment-Nissl sections, the subicular boundaries are reliably recognized because cells of the outer subicular pyramidal layer are known to display unusual accumulations of lipofuscin granules within the middle portions of their apical dendrite [<xref ref-type="bibr" rid="CR23">23</xref>]. 100&#x000a0;&#x000b5;m, AT8 immunoreaction, same individual as in Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref></p></caption><graphic xlink:href="401_2025_2862_Fig11_HTML" id="MO11"/></fig></p><p id="Par31">In sum, the associations between each of the NFT stages I, II, and III, in the absence of A&#x003b2; deposits, and both the eight involved anatomical regions as well as the local layers and structures within each of the eight regions studied were significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Tables <xref rid="Tab7" ref-type="table">3</xref> and <xref rid="Tab8" ref-type="table">4</xref>).</p></sec><sec id="Sec16"><title>Tau-related loss of involved nerve cells during NFT stages I&#x02013;III</title><p id="Par32">An insidious onset of nerve cell loss accompanied NFT stages I&#x02013;III, as indicated by the presence of extraneuronal NTs/NFTs in astrocytes (not shown) and neuronal lipofuscin granules in microglial cells (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>f). Initially, pigment-laden microglial cells as a sign of nerve cell loss were hardly recognizable but became more distinct as the pathological process progressed (Table&#x000a0;<xref rid="Tab9" ref-type="table">5</xref>). The Kruskal&#x02013;Wallis test showed significant regional differences (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for the regions tre/ento, CA1 and CA2, and <italic>p</italic>&#x02009;=&#x02009;0.003 for CA3/CA4/Fd) with regard to neuronal loss in NFT stages I&#x02013;III (Table&#x000a0;<xref rid="Tab9" ref-type="table">5</xref>).</p><p id="Par33">Neuronal loss followed the same sequence as that seen in the development of the tau changes. Thus, the first signs of nerve cell loss occurred in the lateral transentorhinal area (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a), directly abutting the temporal neocortex [<xref ref-type="bibr" rid="CR13">13</xref>]. The densely pigmented pre-&#x003b1; cells at this location contrasted sharply with the accompanying but markedly less strongly pigmented neocortical pyramidal cells. Lost nerve cells at this site were indicated by pigment-laden microglia (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>f).</p><p id="Par34">The ordered progression of morphological changes at each location according to four groups also suggested a potential sequence of focused point-to-point transneuronal tau spreading, i.e., anterogradely from (<bold>1</bold>) involved entorhinal pre-&#x003b1; cells to (2) pyramidal cells of the prosubiculum, CA1, CA2, from there to (3) mossy cells in CA3 and CA4 and, finally, from mossy cells to (4) dentate granular cells and subiculum. The Kruskall-Wallis test results with regard to a possible trajectory of transneuronal tau spreading reached significance (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig12" ref-type="fig">12</xref>).<fig id="Fig12"><label>Fig.&#x000a0;12</label><caption><p>Diagram showing regional trajectory of tau morphological changes by NFT stage from (1) the tre/ento/tr perforans via the perforant path to (2) procubiculum/CA1/CA2, to (3) CA3/CA4, and to (4) the Fd and subiculum. The density of all AT8-positive lesions (pretangle tau, NFTs, NTs) in each of the four groups taken together was semiquantitatively rated as 0&#x02009;=&#x02009;none, 0.5&#x02009;=&#x02009;subtle, 1.0&#x02009;=&#x02009;mild, 2.0&#x02009;=&#x02009;marked, and 3.0&#x02009;=&#x02009;severe to evaluate the possible regional trajectory of tau progression. The Kruskal&#x02013;Wallis test comparing the four groups reached significance (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001)</p></caption><graphic xlink:href="401_2025_2862_Fig12_HTML" id="MO13"/></fig></p></sec></sec><sec id="Sec17"><title>Discussion</title><p id="Par35">The present study is based on the varying regional extent of the AD-related AT8-positive pathology with different degrees of severity that evolves in specific regions of the temporal allocortex The progressive tau changes develop in a stereotypic and systematic manner [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR124">124</xref>]. The average age of the cases increased from 57.4&#x000a0;years in NFT stage I to 69.9&#x000a0;years in stage II, and 75.3&#x000a0;years in stage III (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a&#x02013;c) in concert with the progression of the tau changes.</p><p id="Par36">The earliest changes in stage I cases consist of barely a few AT8-positive dots in isolated axon-like structures and of pretangles in abnormally bent dendritic segments in the transentorhinal/entorhinal layer pre-&#x003b1; [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR25">25</xref>] (Figs. <xref rid="Fig3" ref-type="fig">3</xref>, <xref rid="Fig4" ref-type="fig">4</xref>). Given their size, the AT8-positive dots possibly were pathologically changed terminal axonal boutons generated by affected subcortical nuclei projecting to this cortical field, whereas the abnormally bent dendritic segments could represent axonal terminals combined with abnormally changed AT8-positive distalmost dendritic segments of pre-&#x003b1; projection neurons [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR115">115</xref>] Only a few subcortical nuclei are known to become involved prior to AD-related cortical changes and these include the locus coeruleus, the upper raphe nuclei, and magnocellular nuclei of the basal forebrain [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR111">111</xref>]. The projections of these subcortical nuclei to portions of the cerebral cortex are usually described as &#x02018;diffuse&#x02019; or &#x02018;widely dispersed&#x02019; [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Our findings, however, suggest a more highly focused projection from defined regions of the nuclei to circumscribed portions of the cortex.</p><p id="Par37">Currently, the transmission of the pathological process from one nerve cell to another is thought to proceed via axonal seeds of abnormal tau anterogradely transferring the disease to dendrites of neurons following in the neuronal chain [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR105">105</xref>]. The entorhinal pre-&#x003b1; neurons initially display abnormal tau in only the distal segments of their dendrites (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). Inasmuch as no other portions of an affected cell contain abnormal tau, we and others have concluded that pretangle tau originates from localized sources of tau in dendrites [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR113">113</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. The tau inclusions cause alterations in the shapes of the distal dendrites and possibly stimulate a renewed growth that could explain their final size and tortuosity [<xref ref-type="bibr" rid="CR11">11</xref>]. Thereafter, the proximal dendrites, the cell soma, and the axon become filled with soluble pretangle tau (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>f), which may be toxic [<xref ref-type="bibr" rid="CR78">78</xref>]. With time, the visibility of the dendrites becomes reduced, perhaps because the soluble pretangle tau that generally is uniformly dispersed in the cytoplasm gradually aggregates, consolidating into insoluble and less toxic NTs and NFTs. It remains an open question whether at the same time a reduction in the length and number of dendritic processes occurs.</p><p id="Par38">The AT8-positive axons of pre-&#x003b1; cells that contribute to the formation of the perforant path do not display severe axonal abnormalities (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>d), nor does the presence of abnormal tau appear to severely damage their axonal cytoskeleton. The abnormal tau within the axon, therefore, is unlikely generated from the axonal cytoskeleton itself [<xref ref-type="bibr" rid="CR71">71</xref>]; rather, it represents soluble abnormal tau that has been transferred into the axon from the cell body via the axon hillock [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par39">The presence of AT8-positive interneurons interspersed throughout the perforant path has not been described earlier (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). Although nothing is known about their functions, they appear to be &#x02018;strategically&#x02019; positioned. In general, the AD-related pathological process preferably targets projection neurons, by and large sparing local circuit neurons or interneurons with a short axon [<xref ref-type="bibr" rid="CR23">23</xref>]. It is unknown why this special type of perforant path interneuron consistently develops abnormal tau. It is possible that the initially soluble pretangle tau within the involved interneurons is strongly toxic [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR98">98</xref>]. This could explain why these cells are incapable of developing the less soluble and less toxic neurofibrillary lesions. Instead, they perish shortly after the appearance of abnormal intraneuronal tau. In analogy to ghost tangles, &#x02018;ghost interneurons&#x02019;, are unknown.</p><p id="Par40">It has been reported that an unidirectional sequence of connections leads from dentate granule cells to CA1 within the hippocampal formation [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR127">127</xref>] (Table&#x000a0;<xref rid="Tab7" ref-type="table">3</xref>, <italic>black arrow at left</italic>). Nonetheless, the axons of these known pathways (stratum lucidum mossy fibers, stratum radiatum Schaffer collaterals) remain virtually devoid of AD-related pathology or display only subtle changes [<xref ref-type="bibr" rid="CR23">23</xref>]. Previously, we hypothesized a sequence of neuronal involvement in AD that proceeds, in part, in the opposite direction [<xref ref-type="bibr" rid="CR25">25</xref>] (Table&#x000a0;<xref rid="Tab7" ref-type="table">3</xref>, <italic>black arrow at right</italic>). According to our hypothesis, the disease-related intrahippocampal sequence starts within collaterals of the perforant path that connect the entorhinal region with the hippocampal prosubiculum and CA1/CA2 sectors (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>, <italic>blue and hypothetical green connections</italic> to the stratum oriens). Thereafter, we speculate that it reaches the thorny excrescences and mossy cells in CA3/CA4 (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>, <italic>green connections</italic>, still unverified in primate studies) and, subsequently, via known connections the dentate granule cells (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>, <italic>violet connection at left</italic>). Although the green connections proposed here are still uncertain, nonetheless, the statistical results for the here-proposed directionality of tau progression within the hippocampal formation were significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig12" ref-type="fig">12</xref>). <fig id="Fig13"><label>Fig.&#x000a0;13</label><caption><p>Summary diagram of the here-proposed disease-related intrahippocampal sequence of tau progression. We interpret our findings to mean that a sequence of neuronal involvement in AD could proceed from the entorhinal region to the hippocampal prosubiculum and CA1/CA2 sectors (<italic>blue and green connections</italic>), then to the thorny excrescences of mossy cells in CA3/CA4 (<italic>green connections</italic>), whence it reaches the dentate granular cells (<italic>violet</italic>) [<xref ref-type="bibr" rid="CR25">25</xref>]. The hypothetical pathways appear in <italic>green</italic></p></caption><graphic xlink:href="401_2025_2862_Fig13_HTML" id="MO15"/></fig></p><p id="Par42">In the present study, the initially involved hippocampal projection neurons of the prosubiculum, CA1, and CA2 gradually increased in number. Our findings suggest that this increase may be captured by a uniform mechanism: A single axon generated from cells of the outer entorhinal layers may split into two basic collaterals. Passing the prosubiculum, a basal branch would head downwards and contribute to the formation of the stratum oriens (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>). Close to its target cell, it would split into terminal branches. Each single branch would then terminate on its corresponding basal dendrite in a CA1 or CA2 pyramidal cell (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>). All of the dendrites of a single pyramidal cell would receive contacts from a single branch. None of the terminal collateral branches, however, would establish a connection to another cell in the vicinity. The second branch of the involved entorhinal collateral would follow the course of the perforant path and run within the stratum lacunosum (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>). From there, it would reach side branches of the apical dendrite of the same cell already contacted by the basal branch (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>). A concerted action by both branches then would result in the simultaneous appearance of abnormal pretangle tau in the distalmost portions of both the basal and apical dendrites of a specific nerve cell (identical shading in Table&#x000a0;<xref rid="Tab8" ref-type="table">4</xref> implies that this simultaneous change by both branches may be assigned to the same time frame), suggesting a strongly focused point-to-point transmission from a single axon to a single neuron. Taken together, the distalmost dendritic segments of select hippocampal projection neurons initially bear the brunt of the AD-related tau pathology: A recapitulation of these consecutive alterations is presented schematically in Fig.&#x000a0;<xref rid="Fig14" ref-type="fig">14</xref>. <fig id="Fig14"><label>Fig.&#x000a0;14</label><caption><p>Sketches of the here-proposed sequential development of abnormal tau in CA1 pyramidal cells.<bold> a</bold> Initially, abnormally bent distalmost dendritic segments of involved pyramidal cells become filled with AT8-immunoreactive tau aggregates. <bold>b</bold> Next, pretangle tau emanates from the distal segments into the proximal dendrites, and these lead towards an initially immunonegative center. <bold>c</bold> Gradually, the soma of the affected pyramidal cell becomes AT8-immunopositive. Portions of the distalmost apical dendrite in the stratum moleculare show AT8-immunopositive spindle-shaped varicosities that are unique to the CA1 sector. <bold>d</bold> The dendritic connections to the soma become extremely thin and are finally lost. <bold>e.</bold> Pretangle tau converts to a fibrillar and argyrophilic NFT in the cell soma and to NTs in the dendrites. <bold>f</bold> After cell death, the cellular nucleus disappears. Both the steel wool-like fibrillar tau and the assemblies of lipofuscin granules can then be seen in the extracellular space (neuropil). <bold>g</bold>, <bold>h</bold> The NFTNTs are taken up by astrocytes [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>] and degraded, whereas the remaining neuronal lipofuscin granules are taken up by microglia. These pigmented glial cells eventually disappear from this location</p></caption><graphic xlink:href="401_2025_2862_Fig14_HTML" id="MO17"/></fig></p><p id="Par43">The early tau pathology selectively and severely damages phylo- and ontogenetically late-emerging and late-maturing synapses along the distalmost dendrites [<xref ref-type="bibr" rid="CR29">29</xref>] (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a, b). Notably, these synapses are not essential for the most basic brain functions, i.e., survival [<xref ref-type="bibr" rid="CR23">23</xref>]. Following the development of pathological changes in the prosubiculum/CA1/CA2 sectors, the tau pathology progresses into sectors CA3-CA4 (NFT stages II and III). The forceps-shaped accumulations of abnormal cellular processes in the stratum oriens and stratum lacunosum were seen to have thinned out considerably in CA3 and they were no longer visible in CA4 (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>). This raises questions about whether the subsequent course of the pathological process is still governed by entorhinal axons. Spines along affected dendrites normally remain devoid of abnormal tau. The thorny excrescences of CA3/CA4 projection cells, however, display a notable exception from this rule and show a pronounced and <italic>early</italic> involvement (NFT stage I in Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>f, h). The fact that they were occasionally seen in isolation supports the view that they are the first cellular processes belonging to these cells to become affected. Nearly all of the excrescences of an individual mossy cell showed a faint but simultaneous AT8-positive immunoreaction. Among these were a few darkly stained and slightly larger spines. These spines could be interpreted to represent the actual contact zone for nerve cell-to-nerve cell transmission of tau seeds. The excrescences are known to receive their main afferents from the mossy fibers of dentate granular cells [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR118">118</xref>]. However, at this point in the disease process, granular cells of dentate fascia were largely uninvolved and, thus, unlikely to provide the seeds for transmission of tau to the excrescences. Therefore, we postulate the existence of an additional connection generated by a proportion of already-involved prosubicular/CA1 projection neurons that may, additionally and directly, contact the thorny excrescences of CA3 and CA4 (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>, <italic>green connection</italic>). Again, we speculate that the terminal boutons of a single axon would establish contact with all thorny excrescences of a single mossy cell and with no other immediately adjacent mossy cells.</p><p id="Par44">The task that remains is to determine if the postulated connections based on the sequence of morphological changes described here actually exist (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>, <italic>green connections</italic>) and can be modelled experimentally, or to formulate alternative and sufficient explanations for the distinctive morphological features of the pathological process (Tables <xref rid="Tab7" ref-type="table">3</xref> and <xref rid="Tab8" ref-type="table">4</xref>, Fig.&#x000a0;<xref rid="Fig14" ref-type="fig">14</xref>). The realization of peculiar point-to-point connections between the axon of a single nerve cell to all of the dendrites of the next nerve cell in the neuronal chain, and this in the absence of contacts to adjacent neurons, is conspicuous and as yet unreported in the literature on point-to-point data transmission.</p><p id="Par45">Finally, axonal projections of the multipolar CA4 mossy cells are known to terminate in the internal one-third of the dentate molecular layer [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]. These projections also could possibly serve as a conduit for the disease process to the granular cells of the dentate fascia. Terminal branches of the perforant path, by contrast, fill from the outset of the pathological process the outer two-thirds of the molecular layer, but they are probably not responsible for the transmission of AD-related tau seeds, inasmuch as the involvement of the granular cells is a late event that occurs only after the development of abnormally altered axonal terminals in the inner third of the molecular layer, i.e., following the appearance of involved CA4 mossy cells. It remains enigmatic why the involved axon terminals of the perforant path in the outer two-thirds of the dentate (Fd) molecular layer refrain from transmitting tau seeds.</p><p id="Par46">Larger amounts of abnormal tau occur comparatively late (from NFT stage III onwards) in the output region of the hippocampus, the subiculum. It receives information from CA1. CA1 pyramidal neurons become involved early and, for this reason, we currently have no explanation for the delayed involvement of the subiculum to tau inclusions. This problem could be resolved by future studies.</p><p id="Par47">Loss of tau-positive neurons that occurs during the course of the disease documents itself in overview stainings, such as the pigment-Nissl (PN) method (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>, Suppl. Figure&#x000a0;3): After cell death, the neurofibrillary inclusions and intraneuronal deposits of lipofuscin granules lie in the extracellular space [<xref ref-type="bibr" rid="CR11">11</xref>] (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>, Suppl. Fig.&#x000a0;3). Astrocytes are known to phagocytose ghost tangles [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>], whereas the neuronal lipofuscin granules can be taken up by microglia (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>c&#x02013;f). The occurrence of neuronal lipofuscin in microglial cells is a useful marker of loss of pigment-laden nerve cells. Owing to their smaller size, the pigment-laden microglial cells can be distinguished from the comparatively voluminous pigment-laden hippocampal interneurons [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. A localized loss of pigment-laden pre-&#x003b1; cells in the lateral transentorhinal area, for instance, clearly marks the beginning of the long-lasting process of AD-related loss of nerve cells (Table&#x000a0;<xref rid="Tab9" ref-type="table">5</xref>, Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>b).<table-wrap id="Tab9"><label>Table&#x000a0;5</label><caption><p>Neuronal loss according to NFT stages I&#x02013;III</p></caption><graphic position="anchor" xlink:href="401_2025_2862_Tab9_HTML" id="MO12"/><table-wrap-foot><p>Neuronal loss in each region at each NFT stage was determined based on the presence of extraneuronal lipofuscin granules and pigment-containing microglia as markers of lost pigment-laden nerve cells. It was semiquantitatively assessed as 0&#x02009;=&#x02009;none, 0.5&#x02009;=&#x02009;subtle, 1.0&#x02009;=&#x02009;mild, 2.0&#x02009;=&#x02009;marked, and 3.0&#x02009;=&#x02009;severe. Boxplots display median values (lines marked in <italic>red</italic>) and quartiles (upper and lower box limits); given the discontinuous rating scale these cannot always be distinguished. Based on these data, it can be seen that the difference between NFT stages is all the more pronounced the earlier the region in question is located in the cascade, i.e., that the progression of neuronal loss starts in tre/ento and continues through CA1, CA2, CA3, and CA4 to Fd. Whereas it becomes clear that higher ratings (up to 3) can be observed in the early-involved regions (tre/ento, CA1) and that these occur in NFT stage III, this effect, if at all, disappears in late-involved regions: CA2 tended to have higher ratings in NFT II and III, while in CA3/CA4/Fd there was no longer any difference between NFT I, II and II,I and the ratings there in general only ranged between 0 and 0.5</p><p><italic>tre/ento</italic> transentorhinal/entorhinal regions, <italic>CA1-CA4</italic> cornu Ammonis (Ammon&#x02019;s horn) sectors 1&#x02013;4, <italic>Fd</italic> dentate fascia</p></table-wrap-foot></table-wrap></p><p id="Par48">Attempts have been made to separate the here-described early phase of abnormal tau from the AD-related process. Oligomeric A&#x003b2; is commonly considered as the driver and initiator of the development of abnormal tau in AD [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR108">108</xref>; but see also <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR107">107</xref>]. According to this traditional view, brains that develop tau pathology in the absence of A&#x003b2; deposition is thought to represent a separate tauopathy (PART) that bears little or no relationship to the AD process. The postulated entity is described as a disease of elderly individuals, in whom tau inclusions remain restricted to medial portions of the temporal lobe [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. If, however, such cases are not on the AD continuum, they should commence in old age and show a numerical increase with increasing age. Our data, by contrast, show a Gaussian distribution of cases lacking A&#x003b2; plaques across nearly the entire life span (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). This contradicts the concept of an &#x02018;age-related&#x02019; tauopathy that is separate from AD [<xref ref-type="bibr" rid="CR44">44</xref>]. Moreover, the postulated entity&#x02014;with advancing age&#x02014;should hardly show fresh pretangle-containing nerve cells and, at the same time, increasing signs of neuronal loss. We did not find such cases in the present cohort, nor have they been reported in publications by other groups to date [<xref ref-type="bibr" rid="CR129">129</xref>].</p><p id="Par49">If the AD-related pathological process were indeed to be driven by the presence of A&#x003b2;, we would expect to find an abrupt appearance of abnormal tau in the temporal allocortex, i.e., a distribution of tau lesions corresponding to NFT stage III. Furthermore, such cases should almost exclusively display cells confined to the pretangle phase, and this is in the virtual absence of fibrillar NTs/NFTs or signs of nerve cell loss. However, of the N&#x02009;=&#x02009;308 cases examined here, none displayed this profile. Thus, until the existence of such a pathological profile can be demonstrated, we think that the PART hypothesis is incorrect [<xref ref-type="bibr" rid="CR38">38</xref>].</p><p id="Par50">With increasing age, the Gaussian distribution of the cases shows a gradual decline (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). This suggests that the early tau pathology is, with increasing age and step-by-step, replaced by later (higher) NFT stages. In other words, the early NFT stages are a necessary precondition for the later stages that result in the clinically detectable phase of AD [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR116">116</xref>].</p><sec id="Sec18"><title>APOE status in early AD cases</title><p id="Par51">Whereas the genotypes APOE &#x003b5;2/&#x003b5;2 and &#x003b5;2/&#x003b5;3 are associated with a reduced risk for late-onset AD (AD-related neuropathologic change, ADNC), and the age of AD onset increases with the number of APOE2 alleles, the &#x003b5;4 allele of the apolipoprotein gene E is a major genetic risk factor for sporadic AD [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR125">125</xref>], TDP-43 proteinopathy, and Parkinson&#x02019;s disease [<xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR126">126</xref>]. Individuals with the genotypes APOE &#x003b5;3/&#x003b5;4 or APOE <italic>&#x003b5;</italic>4/&#x003b5;4 have a two-fold to 12-fold increased risk for developing AD; the age-at-onset decreases with the number of an APOE &#x003b5;4 alleles [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. A recent study regards the genotype APOE &#x003b5;2/&#x003b5;4 as a risk factor for developing more severe AD-related pathology (especially A&#x003b2;), mild cognitive impairment (MCI), and late-onset AD [<xref ref-type="bibr" rid="CR97">97</xref>]. Notably, APOE &#x003b5;4 may influence tau inclusions independently of A&#x003b2; deposition, and high tau seeding activity has been reported in APOE &#x003b5;4/&#x003b5;4 carriers [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR109">109</xref>].</p><p id="Par52">Here, APOE genotyping was available for 188/308 individuals (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Our cohort included 2 &#x003b5;2/&#x003b5;2 carriers, 39 &#x003b5;2/&#x003b5;3, 50 &#x003b5;2/&#x003b5;4, 63 &#x003b5;3/&#x003b5;3, 31 &#x003b5;3/&#x003b5;4, and 3 &#x003b5;4/&#x003b5;4 carriers. Forty-one (21.81%) were &#x003b5;2/&#x003b5;2 and &#x003b5;2/&#x003b5;3 carriers and, therefore, were unlikely at higher risk for progressing to clinical AD. On the other hand, the presence of the human &#x003b5;4 isoform is recognized as a major risk factor for sporadic AD. In our sample, 44.68% (84 of 188) individuals possessed an APOE &#x003b5;4 allele (i.e., APOE &#x003b5;2/&#x003b5;4, &#x003b5;3/&#x003b5;4, &#x003b5;4/&#x003b5;4). We presume that all of them were at higher risk for developing clinical AD, including those at younger ages [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR97">97</xref>] (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). The percentages for our &#x003b5;2/&#x003b5;2 (1.06%) and &#x003b5;4/&#x003b5;4 (1.6%) carriers approximated those in the general population. The allele frequencies for <bold>&#x003b5;</bold>2 and &#x003b5;4 were elevated (overrepresented), and the &#x003b5;3 frequency was lowered (underrepresented) in comparison to the general population (Table&#x000a0;<xref rid="Tab3" ref-type="table">2</xref>b, <xref rid="Tab4" ref-type="table">2</xref>c, <xref rid="Tab5" ref-type="table">2</xref>d). The mean ages for the various APOE genotypes hardly differed; thus, age did not play a role with regard to the genotypes in this cohort (Table&#x000a0;<xref rid="Tab6" ref-type="table">2</xref>e). In addition, when using the contingency table and chi-square statistics (chi-square test&#x02009;=&#x02009;3.06, p&#x02009;=&#x02009;0.38), no significant difference was found in the distribution of &#x003b5;4 carriers across all age groups (20&#x02013;100&#x000a0;years). However, the frequency of &#x003b5;4 carriers in the age group&#x02009;&#x0003c;&#x02009;50&#x000a0;years was lowest (31.3%) and highest (64%) in the age group between 50 and 60&#x000a0;years. Typically, in autopsy-based studies, the frequency of &#x003b5;4 carriers seems to be highest, particularly in the age group 50&#x02013;60&#x000a0;years given the selective mortality of &#x003b5;4 carriers, inasmuch as the &#x003b5;4 allele has detrimental effects on longevity, e.g., cardiovascular complications.</p></sec><sec id="Sec19"><title>Study strengths and limitations</title><p id="Par53">A major strength of our study is that the histopathological workup for our early AD cases using the AT8 antibody originated from a single laboratory and, therefore, did not require harmonization of disparate institutional protocols. In addition, we excluded brains displaying comorbidities (mixed pathologies) that could have confounded our findings by influencing the presence and/or severity of the tau inclusions in our sample, or that could have impacted negatively on cognitive function [<xref ref-type="bibr" rid="CR103">103</xref>]. A limitation that exists is inherent in cross-sectional studies, namely, any attempt to establish a sequence of processes or pathological changes based on isolated time points, e.g., at autopsy, results in hypotheses that are, by nature, not definitive. As such, the tau spreading hypothesis we proposed here and previously [<xref ref-type="bibr" rid="CR25">25</xref>] requires testing and confirmation in large prospective longitudinal clinicopathological studies by independent laboratories.</p><p id="Par54">In a recent study by the Giasson group [<xref ref-type="bibr" rid="CR128">128</xref>], the authors, who used the antibody CP13 in addition to AT8 and a novel non-commercially tau antibody 3G12 (Ser208 that may also be a part of the classic AT8 epitope; see [<xref ref-type="bibr" rid="CR87">87</xref>]), reported that the antibodies AT8, CP13, and 7F2 showed similar staining in human hippocampal sections for NFT, dystrophic neurites around neuritic plaques, and neuropil threads (see also their Figs. <xref rid="Fig5" ref-type="fig">5</xref>, <xref rid="Fig6" ref-type="fig">6</xref> and <xref rid="Fig7" ref-type="fig">7</xref> there comparing AT8 with CP13). AT8 has a high affinity for tau phosphorylated at S202 and T205, CP13 for tau phosphorylated at S202. Both antibodies recognize monomeric and assembled tau, with AT8 being easier to visualize because of the local concentration of phosphorylated tau. AT8, the antibody used here, is an exceptionally high-quality antibody. Thus, we have no reason to believe that CP13 shows an earlier stage of tau pathology than the current gold standard AT8 [<xref ref-type="bibr" rid="CR67">67</xref>]. This would have to mean that S202 becomes phosphorylated before T205 in a tangle (neurofibrillary) tau and that the affinity of CP13 for phosphorylated tau is comparable to that of AT8.</p><p id="Par55">A second study limitation is that APOE genotyping was only available for 188/308 (61%) cases and that the &#x003b5;4 and &#x003b5;2 alleles were overrepresented in our cohort compared to the general population [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR88">88</xref>] (Table&#x000a0;<xref rid="Tab4" ref-type="table">2</xref>c). However, notably and in contrast to a previous study [<xref ref-type="bibr" rid="CR90">90</xref>], the elevated frequency <italic>&#x003b5;</italic>4 allele was associated here with definite PART.</p><p id="Par56">Because we had no controls, the overrepresentation of the &#x003b5;2/&#x003b5;4 genotype cannot have resulted from a technical error; rather, the selection bias is anticipated and &#x02018;normal&#x02019;, as it were, inasmuch as we intentionally included 308 cases according to their underlying tau pathology: Cognitively unimpaired individuals of all ages were selected provided they had low NFT stages and lacked A&#x003b2; deposits. As such, it is not surprising that the &#x003b5;2 allele frequency was elevated because cases with A&#x003b2; were excluded. The &#x003b5;2/&#x003b5;3 genotype frequency was also elevated, but this, too, would be typical for a cohort such as ours that lacked A&#x003b2; deposition [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]. Moreover, we excluded a very large number of co-occurring pathologies (e.g., hippocampal sclerosis, non-AD tauopathies, synucleinopathies, and ischemic stroke). Therefore, the available APOE genotypes are simply linked to this special population, which has not been studied in this manner previously and is most likely not representative of the average general population with mixed pathologies [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. In other words, the selection bias was intentional and attributable to our highly selective criteria. This accounts for the deviation in allele frequencies (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).</p></sec></sec><sec id="Sec20"><title>Conclusions</title><p id="Par57">Here, we could show significant associations between early NFT stages I&#x02013;III devoid of A&#x003b2; deposition and (<bold>1</bold>) anatomical regions as well as local specific cellular layers within each region displaying abnormal morphological changes (Tables <xref rid="Tab7" ref-type="table">3</xref>, <xref rid="Tab8" ref-type="table">4</xref> both <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), (<bold>2</bold>) the here-proposed trend of tau progression within the hippocampal formation (Fig.&#x000a0;<xref rid="Fig12" ref-type="fig">12</xref>, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), and (<bold>3</bold>) tau-related neuronal loss (Table&#x000a0;<xref rid="Tab9" ref-type="table">5</xref>, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for transentorhinal/entorhinal regions, CA1/CA2; <italic>p</italic>&#x02009;=&#x02009;0.003 for CA3/CA4/Fd). SYP-immunoreacitve presynapses were AT8-immunoreactive in early-stage AD (NFT stage I). Taken together, these findings are at least indirectly supportive of the anterograde spreading of tau inclusions within the allocortex, and they are supported by results from macaques, in which abnormal tau can arise independently of A&#x003b2; [<xref ref-type="bibr" rid="CR37">37</xref>]. Our findings are incompatible with (<bold>1</bold>) the hypothesis that the presence of A&#x003b2; deposits is mandatory for the development of abnormal tau inclusions and neuronal loss in AD as well as (<bold>2</bold>) the concept that distinct neuropathological criteria should be applied to definite PART and AD. Thus, further inquiries and insights into the early tau phases during which A&#x003b2; deposition is lacking continue to be of fundamental significance for AD pathogenesis and are indispensable for the development of therapeutic interventions.</p></sec><sec id="Sec21" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="401_2025_2862_MOESM1_ESM.docx"><caption><p>Supplementary file1 (DOCX 3741 kb)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Michael Sch&#x000f6;n, Kelly Del Tredici are joint senior authors.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are grateful to the patients and their families, who made brain donation possible. They also thank the Braak Collection (Goethe University Frankfurt am Main) and the Hans &#x00026; Ilse Breuer Foundation (Frankfurt am Main). In particular, we thank our colleagues Michel Goedert MD and Albert C. Ludolph MD for friendship and longstanding advice, as well as Mr. David Ewert (layout, graphics) from the University of Ulm for skillful technical assistance (figure layout). <italic>In memoriam of our colleague</italic>: Michael Frotscher MD (1951-2022) from the Institute for Structural Neurobiology, Center for Molecular Neurobiology Hamburg (ZNMH), University of Hamburg, Hamburg-Eppendorf, Germany.</p></ack><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL. This study was supported by the Hans and Ilse Breuer Foundation, Frankfurt am Main, Germany (HB, KDT).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data that support the findings of this study are obtainable from the corresponding author upon reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par58">The authors have no current or potential conflicts of interest to report.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>Z</given-names></name><name><surname>Cooper</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>TK</given-names></name><name><surname>Garn</surname><given-names>K</given-names></name><name><surname>McNaughton</surname><given-names>E</given-names></name><name><surname>Clark</surname><given-names>H</given-names></name><etal/></person-group><article-title>A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity</article-title><source>Acta Neuropathol</source><year>2014</year><volume>127</volume><fpage>667</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1007/s00401-014-1254-6</pub-id><pub-id pub-id-type="pmid">24531916</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Ahmed Z, Cooper J, Murray TK, Garn K, McNaughton E, Clark H et al (2014) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 127:667&#x02013;683. 10.1007/s00401-014-1254-6<pub-id pub-id-type="pmid">24531916</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Alafuzoff</surname><given-names>I</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>Al-Sarraj</surname><given-names>S</given-names></name><name><surname>Bodi</surname><given-names>I</given-names></name><name><surname>Bogdanovic</surname><given-names>N</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name><etal/></person-group><article-title>Staging of neurofibrillary pathology in Alzheimer&#x02019;s disease: a study for the BrainNet Europe Consortium</article-title><source>Brain Pathol</source><year>2008</year><volume>18</volume><fpage>484</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3639.2008.00147.x</pub-id><pub-id pub-id-type="pmid">18371174</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H et al (2008) Staging of neurofibrillary pathology in Alzheimer&#x02019;s disease: a study for the BrainNet Europe Consortium. Brain Pathol 18:484&#x02013;496. 10.1111/j.1750-3639.2008.00147.x<pub-id pub-id-type="pmid">18371174</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Arendt</surname><given-names>T</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain</article-title><source>Neurobiol Aging</source><year>2000</year><volume>21</volume><fpage>783</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1016/s0197-4580(00)00216-5</pub-id><pub-id pub-id-type="pmid">11124422</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Arendt T (2000) Alzheimer&#x02019;s disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol Aging 21:783&#x02013;796. 10.1016/s0197-4580(00)00216-5<pub-id pub-id-type="pmid">11124422</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Arendt</surname><given-names>T</given-names></name><name><surname>Stieler</surname><given-names>J</given-names></name><name><surname>Ueberham</surname><given-names>U</given-names></name></person-group><article-title>Is sporadic Alzheimer&#x02019;s disease a developmental disorder?</article-title><source>J Neurochem</source><year>2017</year><volume>143</volume><fpage>396</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1111/jnc.14036</pub-id><pub-id pub-id-type="pmid">28397252</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Arendt T, Stieler J, Ueberham U (2017) Is sporadic Alzheimer&#x02019;s disease a developmental disorder? J Neurochem 143:396&#x02013;408. 10.1111/jnc.14036<pub-id pub-id-type="pmid">28397252</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>A</given-names></name><name><surname>Datta</surname><given-names>D</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name></person-group><article-title>Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer&#x02019;s disease</article-title><source>Alzheimer&#x02019;s Dement</source><year>2021</year><volume>17</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1002/alz.12192</pub-id><pub-id pub-id-type="pmid">33075193</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Arnsten A, Datta D, Del Tredici K, Braak H (2021) Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer&#x02019;s disease. Alzheimer&#x02019;s Dement 17:115&#x02013;124. 10.1002/alz.12192<pub-id pub-id-type="pmid">33075193</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Augustinack</surname><given-names>JC</given-names></name><name><surname>Helmer</surname><given-names>K</given-names></name><name><surname>Huber</surname><given-names>KE</given-names></name><name><surname>Kakunoori</surname><given-names>S</given-names></name><name><surname>Z&#x000f6;llei</surname><given-names>L</given-names></name><name><surname>Fischl</surname><given-names>B</given-names></name></person-group><article-title>Direct visualization of the perforant pathway in the human brain with ex vivo diffusion tensor imaging</article-title><source>Front Hum Neurosci</source><year>2010</year><volume>28</volume><issue>4</issue><fpage>42</fpage><pub-id pub-id-type="doi">10.3389/fnhum.2010.00042</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Augustinack JC, Helmer K, Huber KE, Kakunoori S, Z&#x000f6;llei L, Fischl B (2010) Direct visualization of the perforant pathway in the human brain with ex vivo diffusion tensor imaging. Front Hum Neurosci 28(4):42. 10.3389/fnhum.2010.00042</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Belloy</surname><given-names>ME</given-names></name><name><surname>Napolioni</surname><given-names>V</given-names></name><name><surname>Greicius</surname><given-names>MD</given-names></name></person-group><article-title>A quarter century of APOE and Alzheimer&#x02019;s disease: progress to date and the path forward</article-title><source>Neuron</source><year>2019</year><volume>101</volume><fpage>820</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.01.056</pub-id><pub-id pub-id-type="pmid">30844401</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Belloy ME, Napolioni V, Greicius MD (2019) A quarter century of APOE and Alzheimer&#x02019;s disease: progress to date and the path forward. Neuron 101:820&#x02013;838. 10.1016/j.neuron.2019.01.056<pub-id pub-id-type="pmid">30844401</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Betts</surname><given-names>MJ</given-names></name><name><surname>Kirilina</surname><given-names>E</given-names></name><name><surname>Otaduy</surname><given-names>MCG</given-names></name><name><surname>Ivanov</surname><given-names>D</given-names></name><name><surname>Acosta-Cabronero</surname><given-names>J</given-names></name><name><surname>Callaghan</surname><given-names>MF</given-names></name><etal/></person-group><article-title>Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases</article-title><source>Brain</source><year>2019</year><volume>142</volume><fpage>2558</fpage><lpage>2571</lpage><pub-id pub-id-type="doi">10.1093/brain/awz193</pub-id><pub-id pub-id-type="pmid">31327002</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF et al (2019) Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain 142:2558&#x02013;2571. 10.1093/brain/awz193<pub-id pub-id-type="pmid">31327002</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Blazquez-Llorca</surname><given-names>L</given-names></name><name><surname>Garcia-Marin</surname><given-names>V</given-names></name><name><surname>Merino-Serrais</surname><given-names>P</given-names></name><name><surname>Avila</surname><given-names>J</given-names></name><name><surname>DeFelipe</surname><given-names>J</given-names></name></person-group><article-title>Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer&#x02019;s disease</article-title><source>J Alzheimer Dis</source><year>2011</year><volume>23</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.3233/JAD-2011-110659</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Blazquez-Llorca L, Garcia-Marin V, Merino-Serrais P, Avila J, DeFelipe J (2011) Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer&#x02019;s disease. J Alzheimer Dis 23:1&#x02013;16. 10.3233/JAD-2011-110659</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>E</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon&#x02019;s horn</article-title><source>Acta Neuropathol</source><year>1997</year><volume>93</volume><fpage>323</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1007/s004010050622</pub-id><pub-id pub-id-type="pmid">9113196</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Braak E, Braak H (1997) Alzheimer&#x02019;s disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon&#x02019;s horn. Acta Neuropathol 93:323&#x02013;325. 10.1007/s004010050622<pub-id pub-id-type="pmid">9113196</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>E</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Mandelkow</surname><given-names>EM</given-names></name></person-group><article-title>A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads</article-title><source>Acta Neuropathol</source><year>1994</year><volume>87</volume><fpage>554</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1007/BF00293315</pub-id><pub-id pub-id-type="pmid">7522386</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554&#x02013;567. 10.1007/BF00293315<pub-id pub-id-type="pmid">7522386</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="book"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name></person-group><source>Architectonics of the human telencephalic cortex</source><year>1980</year><publisher-loc>Berlin</publisher-loc><publisher-name>Springer</publisher-name></element-citation><mixed-citation id="mc-CR12" publication-type="book">Braak H (1980) Architectonics of the human telencephalic cortex. Springer, Berlin</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer&#x02019;s disease</article-title><source>Acta Neuropathol</source><year>1985</year><volume>68</volume><fpage>325</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1007/BF00690836</pub-id><pub-id pub-id-type="pmid">4090943</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Braak H, Braak E (1985) On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer&#x02019;s disease. Acta Neuropathol 68:325&#x02013;332. 10.1007/BF00690836<pub-id pub-id-type="pmid">4090943</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name><name><surname>Grundke-Iqbal</surname><given-names>I</given-names></name><name><surname>Iqbal</surname><given-names>K</given-names></name></person-group><article-title>Occurrence of neuropil threads in the senile human brain and in Alzheimer&#x02019;s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques</article-title><source>Neurosci Lett</source><year>1986</year><volume>65</volume><fpage>351</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(86)90288-0</pub-id><pub-id pub-id-type="pmid">2423928</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Braak H, Braak E, Grundke-Iqbal I, Iqbal K (1986) Occurrence of neuropil threads in the senile human brain and in Alzheimer&#x02019;s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65:351&#x02013;351<pub-id pub-id-type="pmid">2423928</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>Neuropil threads occur in dendrites of tangle-bearing nerve cells</article-title><source>Neuropathol Appl Neurobiol</source><year>1988</year><volume>14</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2990.1988.tb00864.x</pub-id><pub-id pub-id-type="pmid">2453810</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Braak H, Braak E (1988) Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol Appl Neurobiol 14:39&#x02013;44. 10.1111/j.1365-2990.1988.tb00864.x<pub-id pub-id-type="pmid">2453810</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes</article-title><source>Neurosci Lett</source><year>1987</year><volume>76</volume><fpage>124</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(87)90204-7</pub-id><pub-id pub-id-type="pmid">2438598</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Braak H, Braak E (1987) Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 76:124&#x02013;127. 10.1016/0304-3940(87)90204-7<pub-id pub-id-type="pmid">2438598</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia</article-title><source>Neuropathol Appl Neurobiol</source><year>1989</year><volume>15</volume><fpage>13</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2990.1989.tb01146.x</pub-id><pub-id pub-id-type="pmid">2471109</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Braak H, Braak E (1989) Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 15:13&#x02013;26. 10.1111/j.1365-2990.1989.tb01146.x<pub-id pub-id-type="pmid">2471109</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>Neuropathological stageing of Alzheimer-related changes</article-title><source>Acta Neuropathol</source><year>1991</year><volume>82</volume><fpage>239</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1007/BF00308809</pub-id><pub-id pub-id-type="pmid">1759558</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239&#x02013;259. 10.1007/BF00308809<pub-id pub-id-type="pmid">1759558</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections</article-title><source>Brain Pathol</source><year>1991</year><volume>1</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3639.1991.tb00661.x</pub-id><pub-id pub-id-type="pmid">1669710</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213&#x02013;216. 10.1111/j.1750-3639.1991.tb00661.x<pub-id pub-id-type="pmid">1669710</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases</article-title><source>Neurosci Res</source><year>1992</year><volume>15</volume><fpage>6</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/0168-0102(92)90014-4</pub-id><pub-id pub-id-type="pmid">1336586</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Braak H, Braak E (1992) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15:6&#x02013;31. 10.1016/0168-0102(92)90014-4<pub-id pub-id-type="pmid">1336586</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>The pathological process underlying Alzheimer&#x02019;s disease in individuals under thirty</article-title><source>Acta Neuropathol</source><year>2011</year><volume>121</volume><fpage>171</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1007/s00401-010-0789-4</pub-id><pub-id pub-id-type="pmid">21170538</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer&#x02019;s disease in individuals under thirty. Acta Neuropathol 121:171&#x02013;181. 10.1007/s00401-010-0789-4<pub-id pub-id-type="pmid">21170538</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>Are cases with tau pathology occurring in the absence of A&#x003b2; deposits part of the AD-related pathological process?</article-title><source>Acta Neuropathol</source><year>2014</year><volume>128</volume><fpage>767</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1007/s00401-014-1356-1</pub-id><pub-id pub-id-type="pmid">25359108</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Braak H, Del Tredici K (2014) Are cases with tau pathology occurring in the absence of A&#x003b2; deposits part of the AD-related pathological process? Acta Neuropathol 128:767&#x02013;772. 10.1007/s00401-014-1356-1<pub-id pub-id-type="pmid">25359108</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>Neuroanatomy and pathology of sporadic Alzheimer&#x02019;s disease</article-title><source>Adv Anat Embryol Cell Biol</source><year>2015</year><volume>215</volume><fpage>1</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-12679-1_1</pub-id><pub-id pub-id-type="pmid">25920101</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Braak H, Del Tredici K (2015) Neuroanatomy and pathology of sporadic Alzheimer&#x02019;s disease. Adv Anat Embryol Cell Biol 215:1&#x02013;162<pub-id pub-id-type="pmid">25920101</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>Spreading of tau pathology in sporadic Alzheimer&#x02019;s disease along cortico-cortical top-down connections</article-title><source>Cereb Cortex</source><year>2018</year><volume>28</volume><fpage>3372</fpage><lpage>3384</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhy152</pub-id><pub-id pub-id-type="pmid">29982389</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Braak H, Del Tredici K (2018) Spreading of tau pathology in sporadic Alzheimer&#x02019;s disease along cortico-cortical top-down connections. Cereb Cortex 28:3372&#x02013;3384. 10.1093/cercor/bhy152<pub-id pub-id-type="pmid">29982389</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>From the entorhinal region via the prosubiculum to the dentate fascia: Alzheimer disease-related neurofibrillary changes in the temporal allocortex</article-title><source>J Neuropathol Exp Neurol</source><year>2020</year><volume>79</volume><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1093/jnen/nlz123</pub-id><pub-id pub-id-type="pmid">31913466</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Braak H, Del Tredici K (2020) From the entorhinal region via the prosubiculum to the dentate fascia: Alzheimer disease-related neurofibrillary changes in the temporal allocortex. J Neuropathol Exp Neurol 79:163&#x02013;175. 10.1093/jnen/nlz123<pub-id pub-id-type="pmid">31913466</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Alafuzoff</surname><given-names>I</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>Kretzschmar</surname><given-names>H</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>Staging of Alzheimer&#x02019;s disease-associated neurofibrillary pathology using paraffin sections and immunohistochemistry</article-title><source>Acta Neuropathol</source><year>2006</year><volume>112</volume><fpage>389</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1007/s00401-006-0127-z</pub-id><pub-id pub-id-type="pmid">16906426</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer&#x02019;s disease-associated neurofibrillary pathology using paraffin sections and immunohistochemistry. Acta Neuropathol 112:389&#x02013;404. 10.1007/s00401-006-0127-z<pub-id pub-id-type="pmid">16906426</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Thal</surname><given-names>DR</given-names></name><name><surname>Ghebremedhin</surname><given-names>E</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years</article-title><source>J Neuropathol Exp Neurol</source><year>2011</year><volume>70</volume><fpage>960</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1097/NEN.0b013e318232a379</pub-id><pub-id pub-id-type="pmid">22002422</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960&#x02013;969. 10.1097/NEN.0b013e318232a379<pub-id pub-id-type="pmid">22002422</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Feldengut</surname><given-names>S</given-names></name><name><surname>Kassubek</surname><given-names>J</given-names></name><name><surname>Yilmazer-Hanke</surname><given-names>D</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name></person-group><article-title>Two histological methods for recognition and study of cortical microinfarctions in thick sections</article-title><source>Eur J Histochem</source><year>2018</year><volume>62</volume><fpage>2989</fpage><pub-id pub-id-type="doi">10.4081/ejh.2018.2989</pub-id><pub-id pub-id-type="pmid">30572697</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Braak H, Feldengut S, Kassubek J, Yilmazer-Hanke D, Del Tredici K (2018) Two histological methods for recognition and study of cortical microinfarctions in thick sections. Eur J Histochem 62:2989. 10.4081/ejh.2018.2989<pub-id pub-id-type="pmid">30572697</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Branco</surname><given-names>T</given-names></name><name><surname>H&#x000e4;usser</surname><given-names>M</given-names></name></person-group><article-title>Synaptic integration gradients in single cortical pyramidal cell dendrites</article-title><source>Neuron</source><year>2011</year><volume>69</volume><fpage>885</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.02.006</pub-id><pub-id pub-id-type="pmid">21382549</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Branco T, H&#x000e4;usser M (2011) Synaptic integration gradients in single cortical pyramidal cell dendrites. Neuron 69:885&#x02013;892. 10.1016/j.neuron.2011.02.006<pub-id pub-id-type="pmid">21382549</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Brettschneider</surname><given-names>J</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>VMY</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name></person-group><article-title>Spreading of pathology in neurodegenerative diseases: a focus on human studies</article-title><source>Nat Rev Neurosci</source><year>2015</year><volume>16</volume><fpage>109</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1038/nrn3887</pub-id><pub-id pub-id-type="pmid">25588378</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Brettschneider J, Del Tredici K, Lee VMY, Trojanowski JQ (2015) Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16:109&#x02013;120. 10.1038/nrn3887<pub-id pub-id-type="pmid">25588378</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Brundin</surname><given-names>P</given-names></name><name><surname>Melki</surname><given-names>R</given-names></name><name><surname>Kopito</surname><given-names>R</given-names></name></person-group><article-title>Prion-like transmission of protein aggregates in neurodegenerative diseases</article-title><source>Nat Rev Mol Cell Biol</source><year>2010</year><volume>11</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1038/nrm2873</pub-id><pub-id pub-id-type="pmid">20308987</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11:301&#x02013;307. 10.1038/nrm2873<pub-id pub-id-type="pmid">20308987</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>SK</given-names></name><name><surname>Switzer</surname><given-names>RC</given-names></name><name><surname>Martin</surname><given-names>TL</given-names></name></person-group><article-title>Alzheimer&#x02019;s plaques and tangles: A controlled and enhanced silver staining method</article-title><source>Soc Neurosci Abstr</source><year>1987</year><volume>13</volume><fpage>678</fpage></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Campbell SK, Switzer RC, Martin TL (1987) Alzheimer&#x02019;s plaques and tangles: A controlled and enhanced silver staining method. Soc Neurosci Abstr 13:678</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Corder</surname><given-names>EH</given-names></name><name><surname>Saunders</surname><given-names>AM</given-names></name><name><surname>Strittmacher</surname><given-names>WJ</given-names></name><name><surname>Schmechel</surname><given-names>DE</given-names></name><name><surname>Gaskell</surname><given-names>PC</given-names></name><name><surname>Small</surname><given-names>GW</given-names></name><etal/></person-group><article-title>Gene dose of apolipoprotein E and type 4 allele and the risk of Alzheimer&#x02019;s disease in late-onset families</article-title><source>Science</source><year>1993</year><volume>261</volume><fpage>921</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1126/science.8346443</pub-id><pub-id pub-id-type="pmid">8346443</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Corder EH, Saunders AM, Strittmacher WJ, Schmechel DE, Gaskell PC, Small GW et al (1993) Gene dose of apolipoprotein E and type 4 allele and the risk of Alzheimer&#x02019;s disease in late-onset families. Science 261:921&#x02013;923. 10.1126/science.8346443<pub-id pub-id-type="pmid">8346443</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Corder</surname><given-names>EH</given-names></name><name><surname>Saunders</surname><given-names>AM</given-names></name><name><surname>Risch</surname><given-names>NJ</given-names></name><name><surname>Schmechel</surname><given-names>DE</given-names></name><name><surname>Gaskell</surname><given-names>PC</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease</article-title><source>Nat Genet</source><year>1994</year><volume>7</volume><fpage>180</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1038/ng0694-180</pub-id><pub-id pub-id-type="pmid">7920638</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Corder EH, Saunders AM, Risch NJ, Schmechel DE, Gaskell PC Jr et al (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7:180&#x02013;184. 10.1038/ng0694-180<pub-id pub-id-type="pmid">7920638</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Crary</surname><given-names>JF</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Schneider</surname><given-names>JA</given-names></name><name><surname>Abisambra</surname><given-names>JF</given-names></name><name><surname>Abner</surname><given-names>EL</given-names></name><name><surname>Alafuzoff</surname><given-names>I</given-names></name><etal/></person-group><article-title>Primary age-related tauopathy (PART): a common pathology associated with human aging</article-title><source>Acta Neuropathol</source><year>2014</year><volume>128</volume><fpage>755</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1007/s00401-014-1349-0</pub-id><pub-id pub-id-type="pmid">25348064</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755&#x02013;766. 10.1007/s00401-014-1349-0<pub-id pub-id-type="pmid">25348064</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Crary</surname><given-names>JF</given-names></name></person-group><article-title>Primary age-related tauopathy and the amyloid cascade hypothesis: the exception that proves the rule?</article-title><source>J Neurol Neuromed</source><year>2016</year><volume>1</volume><fpage>53</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.29245/2572.942x/2016/6.1059</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Crary JF (2016) Primary age-related tauopathy and the amyloid cascade hypothesis: the exception that proves the rule? J Neurol Neuromed 1:53&#x02013;55. 10.29245/2572.942x/2016/6.1059</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname><given-names>D</given-names></name><name><surname>Perone</surname><given-names>I</given-names></name><name><surname>Wijegunawardana</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>F</given-names></name><name><surname>Morozov</surname><given-names>YM</given-names></name><name><surname>Arellano</surname><given-names>J</given-names></name><etal/></person-group><article-title>Nanoscale imaging of pT217-tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: evidence of interneuronal trafficking and early-stage neurodegeneration</article-title><source>Alzheimers Dement</source><year>2024</year><volume>20</volume><fpage>2843</fpage><lpage>2860</lpage><pub-id pub-id-type="doi">10.1002/alz.13737</pub-id><pub-id pub-id-type="pmid">38445818</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Datta D, Perone I, Wijegunawardana D, Liang F, Morozov YM, Arellano J et al (2024) Nanoscale imaging of pT217-tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: evidence of interneuronal trafficking and early-stage neurodegeneration. Alzheimers Dement 20:2843&#x02013;2860. 10.1002/alz.13737<pub-id pub-id-type="pmid">38445818</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Del Tredici</surname><given-names>K</given-names></name><name><surname>Sch&#x000f6;n</surname><given-names>M</given-names></name><name><surname>Feldengut</surname><given-names>S</given-names></name><name><surname>Ghebremedhin</surname><given-names>E</given-names></name><name><surname>Kaufman</surname><given-names>SK</given-names></name><name><surname>Wiesner</surname><given-names>D</given-names></name><etal/></person-group><article-title>Early CA2 tau inclusions do not distinguish an age-related tauopathy from early Alzheimer&#x02019;s disease</article-title><source>J Alzheimers Dis</source><year>2024</year><volume>101</volume><fpage>1333</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.3233/JAD-240483</pub-id><pub-id pub-id-type="pmid">39302368</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Del Tredici K, Sch&#x000f6;n M, Feldengut S, Ghebremedhin E, Kaufman SK, Wiesner D et al (2024) Early CA2 tau inclusions do not distinguish an age-related tauopathy from early Alzheimer&#x02019;s disease. J Alzheimers Dis 101:1333&#x02013;1353. 10.3233/JAD-240483<pub-id pub-id-type="pmid">39302368</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Dickson</surname><given-names>DW</given-names></name></person-group><article-title>Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration</article-title><source>J Neurol</source><year>1999</year><volume>246</volume><fpage>s006</fpage><lpage>s015</lpage><pub-id pub-id-type="doi">10.1007/PL00007746</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:s006-s015. 10.1007/PL00007746</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Dickson</surname><given-names>DW</given-names></name></person-group><article-title>Neuropathology of non-Alzheimer degenerative disorders</article-title><source>Int J Clin Exp Pathol</source><year>2009</year><volume>25</volume><fpage>1</fpage><lpage>23</lpage></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Dickson DW (2009) Neuropathology of non-Alzheimer degenerative disorders. Int J Clin Exp Pathol 25:1&#x02013;23</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Dujardin</surname><given-names>S</given-names></name><name><surname>Commins</surname><given-names>C</given-names></name><name><surname>Lathuiliere</surname><given-names>A</given-names></name><name><surname>Beerepoot</surname><given-names>P</given-names></name><name><surname>Fernandes</surname><given-names>AR</given-names></name><name><surname>Kamath</surname><given-names>TV</given-names></name><etal/></person-group><article-title>Tau molecular diversity contributes to clinical heterogeneity in Alzheimer&#x02019;s disease</article-title><source>Nat Med</source><year>2020</year><volume>26</volume><fpage>1256</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0938-9</pub-id><pub-id pub-id-type="pmid">32572268</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV et al (2020) Tau molecular diversity contributes to clinical heterogeneity in Alzheimer&#x02019;s disease. Nat Med 26:1256&#x02013;1263. 10.1038/s41591-020-0938-9<pub-id pub-id-type="pmid">32572268</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Duyckaerts</surname><given-names>C</given-names></name><name><surname>Hauw</surname><given-names>JJ</given-names></name></person-group><article-title>Prevalence, incidence and duration of Braak's stages in the general population: can we know?</article-title><source>Neurobiol Aging</source><year>1997</year><volume>18</volume><fpage>362</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/s0197-4580(97)00047-x</pub-id><pub-id pub-id-type="pmid">9380250</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Duyckaerts C, Hauw JJ (1997) Prevalence, incidence and duration of Braak&#x02019;s stages in the general population: can we know? Neurobiol Aging 18:362&#x02013;369. 10.1016/s0197-4580(97)00047-x<pub-id pub-id-type="pmid">9380250</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Duyckaerts</surname><given-names>C</given-names></name><name><surname>Delatour</surname><given-names>B</given-names></name><name><surname>Potier</surname><given-names>MC</given-names></name></person-group><article-title>Classification and basic pathology of Alzheimer disease</article-title><source>Acta Neuropathol</source><year>2009</year><volume>118</volume><fpage>5</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/s00401-009-0532-1</pub-id><pub-id pub-id-type="pmid">19381658</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5&#x02013;36. 10.1007/s00401-009-0532-1<pub-id pub-id-type="pmid">19381658</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Duyckaerts</surname><given-names>C</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Brion</surname><given-names>J-P</given-names></name><name><surname>Bu&#x000e9;e</surname><given-names>L</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name><etal/></person-group><article-title>PART is part of Alzheimer disease</article-title><source>Acta Neuropathol</source><year>2015</year><volume>129</volume><fpage>749</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1007/s00401-015-1390-7</pub-id><pub-id pub-id-type="pmid">25628035</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Duyckaerts C, Braak H, Brion J-P, Bu&#x000e9;e L, Del Tredici K, Goedert M et al (2015) PART is part of Alzheimer disease. Acta Neuropathol 129:749&#x02013;756. 10.1007/s00401-015-1390-7<pub-id pub-id-type="pmid">25628035</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Duyckaerts</surname><given-names>C</given-names></name><name><surname>Seilhean</surname><given-names>D</given-names></name><name><surname>Sazdovitch</surname><given-names>V</given-names></name><name><surname>Plu</surname><given-names>I</given-names></name><name><surname>Delatour</surname><given-names>B</given-names></name><name><surname>Potier</surname><given-names>MC</given-names></name></person-group><article-title>Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm</article-title><source>Bull Acad Natl Med</source><year>2015</year><volume>199</volume><fpage>809</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">29901881</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Duyckaerts C, Seilhean D, Sazdovitch V, Plu I, Delatour B, Potier MC (2015) Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm. Bull Acad Natl Med 199:809&#x02013;819<pub-id pub-id-type="pmid">29901881</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrenberg</surname><given-names>AJ</given-names></name><name><surname>Nguy</surname><given-names>AK</given-names></name><name><surname>Theophilas</surname><given-names>P</given-names></name><name><surname>Dunlop</surname><given-names>S</given-names></name><name><surname>Suemoto</surname><given-names>CK</given-names></name><name><surname>Di Lorenzo Alho</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer&#x02019;s disease</article-title><source>Neurol Appl Neurobiol</source><year>2017</year><volume>43</volume><fpage>393</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1111/nan.12387</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Ehrenberg AJ, Nguy AK, Theophilas P, Dunlop S, Suemoto CK, Di Lorenzo Alho AT et al (2017) Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer&#x02019;s disease. Neurol Appl Neurobiol 43:393&#x02013;408. 10.1111/nan.12387</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Feldengut</surname><given-names>S</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name></person-group><article-title>Paraffin sections of 70&#x02013;100 &#x000b5;m: a novel technique and its benefits for studying the nervous system</article-title><source>J Neurosci Methods</source><year>2013</year><volume>15</volume><fpage>241</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2013.03.010</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Feldengut S, Del Tredici K, Braak H (2013) Paraffin sections of 70&#x02013;100 &#x000b5;m: a novel technique and its benefits for studying the nervous system. J Neurosci Methods 15:241&#x02013;244. 10.1016/j.jneumeth.2013.03.010</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Farrer</surname><given-names>LA</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Hyman</surname><given-names>B</given-names></name><name><surname>Kukull</surname><given-names>WA</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium</article-title><source>JAMA</source><year>1997</year><volume>278</volume><fpage>1349</fpage><lpage>1356</lpage><pub-id pub-id-type="doi">10.1001/jama.1997.03550160069041</pub-id><pub-id pub-id-type="pmid">9343467</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349&#x02013;1356. 10.1001/jama.1997.03550160069041<pub-id pub-id-type="pmid">9343467</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer</surname><given-names>I</given-names></name></person-group><article-title>Hypothesis review: Alzheimer&#x02019;s overture guidelines</article-title><source>Brain Pathol</source><year>2023</year><volume>33</volume><fpage>e13122</fpage><pub-id pub-id-type="doi">10.1111/bpa.13122</pub-id><pub-id pub-id-type="pmid">36223647</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Ferrer I (2023) Hypothesis review: Alzheimer&#x02019;s overture guidelines. Brain Pathol 33:e13122. 10.1111/bpa.13122<pub-id pub-id-type="pmid">36223647</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Fillenbaum</surname><given-names>GG</given-names></name><name><surname>van Belle</surname><given-names>G</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Mohs</surname><given-names>RC</given-names></name><name><surname>Mirra</surname><given-names>SS</given-names></name><name><surname>Davis</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years</article-title><source>Alzheimers Dement</source><year>2008</year><volume>4</volume><fpage>96</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2007.08.005</pub-id><pub-id pub-id-type="pmid">18631955</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC et al (2008) Consortium to Establish a Registry for Alzheimer&#x02019;s Disease (CERAD): the first twenty years. Alzheimers Dement 4:96&#x02013;109. 10.1016/j.jalz.2007.08.005<pub-id pub-id-type="pmid">18631955</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Frotscher</surname><given-names>M</given-names></name><name><surname>Seress</surname><given-names>L</given-names></name><name><surname>Schwerdtfeger</surname><given-names>WK</given-names></name><name><surname>Buhl</surname><given-names>E</given-names></name></person-group><article-title>The mossy cells of the fascia dentata: a comparative study of their fine structure and synaptic connections in rodents and primates</article-title><source>J Comp Neurol</source><year>1991</year><volume>312</volume><fpage>145</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1002/cne.903120111</pub-id><pub-id pub-id-type="pmid">1744242</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Frotscher M, Seress L, Schwerdtfeger WK, Buhl E (1991) The mossy cells of the fascia dentata: a comparative study of their fine structure and synaptic connections in rodents and primates. J Comp Neurol 312:145&#x02013;163. 10.1002/cne.903120111<pub-id pub-id-type="pmid">1744242</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Frotscher</surname><given-names>M</given-names></name><name><surname>Jonas</surname><given-names>P</given-names></name><name><surname>Sloviter</surname><given-names>RS</given-names></name></person-group><article-title>Synapses formed by normal and abnormal hippocampal mossy fibers</article-title><source>Cell Tiss Res</source><year>2006</year><volume>326</volume><fpage>361</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1007/s00441-006-0269-2</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Frotscher M, Jonas P, Sloviter RS (2006) Synapses formed by normal and abnormal hippocampal mossy fibers. Cell Tiss Res 326:361&#x02013;367. 10.1007/s00441-006-0269-2</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>JL</given-names></name><name><surname>Vaquer-Alicea</surname><given-names>J</given-names></name><name><surname>White</surname><given-names>CL</given-names></name><name><surname>Cairns</surname><given-names>NJ</given-names></name><name><surname>Nelson</surname><given-names>PT</given-names></name><name><surname>Diamond</surname><given-names>MI</given-names></name></person-group><article-title>Widespread tau seeding activity at early Braak stages</article-title><source>Acta Neuropathol</source><year>2017</year><volume>133</volume><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1007/s00401-016-1644-z</pub-id><pub-id pub-id-type="pmid">27878366</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Furman JL, Vaquer-Alicea J, White CL, Cairns NJ, Nelson PT, Diamond MI (2017) Widespread tau seeding activity at early Braak stages. Acta Neuropathol 133:91&#x02013;100. 10.1007/s00401-016-1644-z<pub-id pub-id-type="pmid">27878366</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Gallyas</surname><given-names>F</given-names></name></person-group><article-title>Silver staining of Alzheimer&#x02019;s neurofibrillary changes by means of physical development</article-title><source>Acta Morph Acad Sci Hung</source><year>1971</year><volume>19</volume><fpage>1</fpage><lpage>8</lpage></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Gallyas F (1971) Silver staining of Alzheimer&#x02019;s neurofibrillary changes by means of physical development. Acta Morph Acad Sci Hung 19:1&#x02013;8</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Genon</surname><given-names>S</given-names></name><name><surname>Bernhardt</surname><given-names>BC</given-names></name><name><surname>La Joie</surname><given-names>R</given-names></name><name><surname>Amunts</surname><given-names>K</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name></person-group><article-title>The many dimensions of human hippocampal (dys)function</article-title><source>Trends Neurosci</source><year>2021</year><volume>44</volume><fpage>977</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2021.10.003</pub-id><pub-id pub-id-type="pmid">34756460</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Genon S, Bernhardt BC, La Joie R, Amunts K, Eickhoff SB (2021) The many dimensions of human hippocampal (dys)function. Trends Neurosci 44:977&#x02013;989. 10.1016/j.tins.2021.10.003<pub-id pub-id-type="pmid">34756460</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Ghebremedhin</surname><given-names>E</given-names></name><name><surname>Schultz</surname><given-names>C</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name></person-group><article-title>High frequency of apolipoprotein E &#x003b5;4 allele in young individuals with very mild Alzheimer&#x02019;s disease-related neurofibrillary changes</article-title><source>Exp Neurol</source><year>1998</year><volume>155</volume><fpage>152</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1006/exnr.1998.6860</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Ghebremedhin E, Schultz C, Braak E, Braak H (1998) High frequency of apolipoprotein E &#x003b5;4 allele in young individuals with very mild Alzheimer&#x02019;s disease-related neurofibrillary changes. Exp Neurol 155:152&#x02013;155. 10.1006/exnr.1998.6860</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><name><surname>Vandermeeren</surname><given-names>E</given-names></name></person-group><article-title>Monoclonal antibody AT8 recognizes tau protein phosphorylated at serine 202 and threonin 205</article-title><source>Neurosci Lett</source><year>1985</year><volume>189</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(95)11484-e</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Goedert M, Jakes R, Vandermeeren E (1985) Monoclonal antibody AT8 recognizes tau protein phosphorylated at serine 202 and threonin 205. Neurosci Lett 189:167&#x02013;170. 10.1016/0304-3940(95)11484-e</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Clavaguera</surname><given-names>F</given-names></name><name><surname>Tolnay</surname><given-names>M</given-names></name></person-group><article-title>The propagation of prion-like protein inclusions in neurodegenerative diseases</article-title><source>Trends Neurosci</source><year>2010</year><volume>33</volume><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2010.04.003</pub-id><pub-id pub-id-type="pmid">20493564</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317&#x02013;325. 10.1016/j.tins.2010.04.003<pub-id pub-id-type="pmid">20493564</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Falcon</surname><given-names>B</given-names></name><name><surname>Clavaguera</surname><given-names>F</given-names></name><name><surname>Tolnay</surname><given-names>M</given-names></name></person-group><article-title>Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies</article-title><source>Curr Neurol Neurosci Rep</source><year>2014</year><volume>14</volume><fpage>495</fpage><pub-id pub-id-type="doi">10.1007/s11910-014-0495-z</pub-id><pub-id pub-id-type="pmid">25218483</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Goedert M, Falcon B, Clavaguera F, Tolnay M (2014) Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies. Curr Neurol Neurosci Rep 14:495. 10.1007/s11910-014-0495-z<pub-id pub-id-type="pmid">25218483</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Arnay</surname><given-names>E</given-names></name><name><surname>P&#x000e9;rez-Santos</surname><given-names>I</given-names></name><name><surname>Jim&#x000e9;nez-S&#x000e1;nchez</surname><given-names>L</given-names></name><name><surname>Cid</surname><given-names>E</given-names></name><name><surname>Gal</surname><given-names>B</given-names></name><name><surname>de la Prida</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Immunohistochemical field parcellation of the human hippocampus along its antero-posterior axis</article-title><source>Brain Struct Funct</source><year>2024</year><volume>229</volume><fpage>359</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1007/s00429-023-02725-9</pub-id><pub-id pub-id-type="pmid">38180568</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Gonz&#x000e1;lez-Arnay E, P&#x000e9;rez-Santos I, Jim&#x000e9;nez-S&#x000e1;nchez L, Cid E, Gal B, de la Prida LM et al (2024) Immunohistochemical field parcellation of the human hippocampus along its antero-posterior axis. Brain Struct Funct 229:359&#x02013;385. 10.1007/s00429-023-02725-9<pub-id pub-id-type="pmid">38180568</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>J</given-names></name></person-group><article-title>An &#x02018;anatomical cascade hypothesis&#x02019; for Alzheimer&#x02019;s disease</article-title><source>Trends Neurosci</source><year>1992</year><volume>15</volume><fpage>200</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/0166-2236(92)90033-5</pub-id><pub-id pub-id-type="pmid">1378661</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Hardy J (1992) An &#x02018;anatomical cascade hypothesis&#x02019; for Alzheimer&#x02019;s disease. Trends Neurosci 15:200&#x02013;201. 10.1016/0166-2236(92)90033-5<pub-id pub-id-type="pmid">1378661</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Heinsen</surname><given-names>H</given-names></name><name><surname>Grinberg</surname><given-names>LT</given-names></name></person-group><article-title>On the origin of tau seeding activity in Alzheimer's disease</article-title><source>Acta Neuropathol</source><year>2018</year><volume>136</volume><fpage>815</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1890-3</pub-id><pub-id pub-id-type="pmid">30039213</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Heinsen H, Grinberg LT (2018) On the origin of tau seeding activity in Alzheimer&#x02019;s disease. Acta Neuropathol 136:815&#x02013;817. 10.1007/s00401-018-1890-3<pub-id pub-id-type="pmid">30039213</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Herrup</surname><given-names>K</given-names></name></person-group><article-title>The case for rejecting the amyloid cascade hypothesis</article-title><source>Nat Neurosci</source><year>2015</year><volume>18</volume><fpage>794</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1038/nn.4017</pub-id><pub-id pub-id-type="pmid">26007212</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Herrup K (2015) The case for rejecting the amyloid cascade hypothesis. Nat Neurosci 18:794&#x02013;799. 10.1038/nn.4017<pub-id pub-id-type="pmid">26007212</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>Bouras</surname><given-names>C</given-names></name><name><surname>Perl</surname><given-names>P</given-names></name><name><surname>Morrison</surname><given-names>JH</given-names></name></person-group><article-title>Quantitative neuropathologic analysis of Pick&#x02019;s disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer&#x02019;s disease</article-title><source>Acta Neuropathol</source><year>1994</year><volume>87</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1007/BF00296179</pub-id><pub-id pub-id-type="pmid">8171960</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Hof PR, Bouras C, Perl P, Morrison JH (1994) Quantitative neuropathologic analysis of Pick&#x02019;s disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer&#x02019;s disease. Acta Neuropathol 87:115&#x02013;124. 10.1007/BF00296179<pub-id pub-id-type="pmid">8171960</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>van Hoesen</surname><given-names>GW</given-names></name><name><surname>Damasio</surname><given-names>AR</given-names></name></person-group><article-title>Memory-related systems in Alzheimer&#x02019;s disease: an anatomic study</article-title><source>Neurology</source><year>1990</year><volume>40</volume><fpage>1721</fpage><lpage>1730</lpage><pub-id pub-id-type="doi">10.1212/wnl.40.11.1721</pub-id><pub-id pub-id-type="pmid">2234428</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Hyman BT, van Hoesen GW, Damasio AR (1990) Memory-related systems in Alzheimer&#x02019;s disease: an anatomic study. Neurology 40:1721&#x02013;1730. 10.1212/wnl.40.11.1721<pub-id pub-id-type="pmid">2234428</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Gom&#x000e9;z-Isla</surname><given-names>T</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease is a laminar, regional, and neural system specific disease, not a global brain disease</article-title><source>Neurobiol Aging</source><year>1994</year><volume>15</volume><fpage>353</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/0197-4580(94)90031-0</pub-id><pub-id pub-id-type="pmid">7936060</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Hyman BT, Gom&#x000e9;z-Isla T (1994) Alzheimer&#x02019;s disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 15:353&#x02013;354. 10.1016/0197-4580(94)90031-0<pub-id pub-id-type="pmid">7936060</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Phelps</surname><given-names>CH</given-names></name><name><surname>Beach</surname><given-names>TG</given-names></name><name><surname>Bigio</surname><given-names>EH</given-names></name><name><surname>Cairns</surname><given-names>NJ</given-names></name><name><surname>Carrillo</surname><given-names>MC</given-names></name><etal/></person-group><article-title>National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease</article-title><source>Alzheimers Dement</source><year>2018</year><volume>8</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2011.10.007</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2018) National Institute on Aging-Alzheimer&#x02019;s Association guidelines for the neuropathologic assessment of Alzheimer&#x02019;s disease. Alzheimers Dement 8:1&#x02013;13. 10.1016/j.jalz.2011.10.007</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Haga</surname><given-names>C</given-names></name><name><surname>Haga</surname><given-names>S</given-names></name></person-group><article-title>Evidence that neurofibrillary tangles undergo glial modification</article-title><source>Acta Neuropathol</source><year>1992</year><volume>85</volume><fpage>101</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1007/BF00304639</pub-id><pub-id pub-id-type="pmid">1285492</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Ikeda K, Akiyama H, Haga C, Haga S (1992) Evidence that neurofibrillary tangles undergo glial modification. Acta Neuropathol 85:101&#x02013;104. 10.1007/BF00304639<pub-id pub-id-type="pmid">1285492</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Haga</surname><given-names>C</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Kase</surname><given-names>K</given-names></name><name><surname>Iritani</surname><given-names>S</given-names></name></person-group><article-title>Coexistence of paired helical filaments and glial filaments in astrocytic processes within ghost tangles</article-title><source>Neurosci Lett</source><year>1992</year><volume>148</volume><fpage>126</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(92)90820-w</pub-id><pub-id pub-id-type="pmid">1338646</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Ikeda K, Haga C, Akiyama H, Kase K, Iritani S (1992) Coexistence of paired helical filaments and glial filaments in astrocytic processes within ghost tangles. Neurosci Lett 148:126&#x02013;128. 10.1016/0304-3940(92)90820-w<pub-id pub-id-type="pmid">1338646</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="book"><person-group person-group-type="author"><name><surname>Insausti</surname><given-names>R</given-names></name><name><surname>Amaral</surname><given-names>DG</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Mai</surname><given-names>JK</given-names></name><name><surname>Paxinos</surname><given-names>G</given-names></name></person-group><article-title>Hippocampal formation</article-title><source>The human nervous system</source><year>2012</year><edition>3</edition><publisher-loc>San Diego</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>896</fpage><lpage>942</lpage></element-citation><mixed-citation id="mc-CR70" publication-type="book">Insausti R, Amaral DG (2012) Hippocampal formation. In: Mai JK, Paxinos G (eds) The human nervous system, 3rd edn. Academic Press, San Diego, pp 896&#x02013;942</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Gong</surname><given-names>CX</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name><name><surname>Grundke-Iqbal</surname><given-names>I</given-names></name></person-group><article-title>Mechanisms of tau-induced neurodegeneration</article-title><source>Acta Neuropathol</source><year>2009</year><volume>118</volume><fpage>53</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1007/s00401-009-0486-3</pub-id><pub-id pub-id-type="pmid">19184068</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Iqbal K, Liu F, Gong CX, Alonso C, Grundke-Iqbal I (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118:53&#x02013;69. 10.1007/s00401-009-0486-3<pub-id pub-id-type="pmid">19184068</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Ittner</surname><given-names>LM</given-names></name><name><surname>Ke</surname><given-names>YD</given-names></name><name><surname>Delerue</surname><given-names>F</given-names></name><name><surname>Bi</surname><given-names>M</given-names></name><name><surname>Gladbach</surname><given-names>A</given-names></name><name><surname>van Eersel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer&#x02019;s disease mouse models</article-title><source>Cell</source><year>2010</year><volume>142</volume><fpage>387</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.06.036</pub-id><pub-id pub-id-type="pmid">20655099</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer&#x02019;s disease mouse models. Cell 142:387&#x02013;397. 10.1016/j.cell.2010.06.036<pub-id pub-id-type="pmid">20655099</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Ittner</surname><given-names>A</given-names></name><name><surname>Ittner</surname><given-names>LM</given-names></name></person-group><article-title>Dendritic tau in Alzheimer&#x02018;s disease</article-title><source>Neuron</source><year>2018</year><volume>11</volume><issue>99</issue><fpage>13</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.06.003</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Ittner A, Ittner LM (2018) Dendritic tau in Alzheimer&#x02018;s disease. Neuron 11(99):13&#x02013;27. 10.1016/j.neuron.2018.06.003</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>HIL</given-names></name><name><surname>Becker</surname><given-names>JA</given-names></name><name><surname>Kwong</surname><given-names>K</given-names></name><name><surname>Engels-Dom&#x000ed;nguez</surname><given-names>N</given-names></name><name><surname>Prokopiou</surname><given-names>PC</given-names></name><name><surname>Papp</surname><given-names>KV</given-names></name><etal/></person-group><article-title>In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline</article-title><source>Sci Transl Med</source><year>2021</year><volume>13</volume><fpage>eabj2511</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.abj2511</pub-id><pub-id pub-id-type="pmid">34550726</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Jacobs HIL, Becker JA, Kwong K, Engels-Dom&#x000ed;nguez N, Prokopiou PC, Papp KV et al (2021) In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer&#x02019;s disease pathology and cognitive decline. Sci Transl Med 13:eabj2511. 10.1126/scitranslmed.abj2511<pub-id pub-id-type="pmid">34550726</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Kametani</surname><given-names>F</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name></person-group><article-title>Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer&#x02018;s disease</article-title><source>Front Neurosci</source><year>2018</year><volume>12</volume><fpage>25</fpage><pub-id pub-id-type="doi">10.3389/fnins.2018.00025</pub-id><pub-id pub-id-type="pmid">29440986</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Kametani F, Hasegawa M (2018) Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer&#x02018;s disease. Front Neurosci 12:25. 10.3389/fnins.2018.00025<pub-id pub-id-type="pmid">29440986</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Karran</surname><given-names>E</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name></person-group><article-title>The amyloid cascade hypothesis: are we poised for success or failure? J Neurochem 139</article-title><source>Suppl</source><year>2016</year><volume>2</volume><fpage>237</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1111/jnc.13632</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Karran E, De Strooper B (2016) The amyloid cascade hypothesis: are we poised for success or failure? J Neurochem 139. Suppl 2:237&#x02013;252. 10.1111/jnc.13632</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>SK</given-names></name><name><surname>Del Tredici</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>TL</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Diamond</surname><given-names>MI</given-names></name></person-group><article-title>Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer&#x02019;s disease and PART</article-title><source>Acta Neuropathol</source><year>2018</year><volume>136</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1855-6</pub-id><pub-id pub-id-type="pmid">29752551</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Kaufman SK, Del Tredici K, Thomas TL, Braak H, Diamond MI (2018) Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer&#x02019;s disease and PART. Acta Neuropathol 136:57&#x02013;67. 10.1007/s00401-018-1855-6<pub-id pub-id-type="pmid">29752551</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Kopelkina</surname><given-names>KJ</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Spires-Jones</surname><given-names>TL</given-names></name></person-group><article-title>Soluble forms of tau are toxic in Alzheimer&#x02019;s disease</article-title><source>Transl Neurosci</source><year>2012</year><volume>3</volume><fpage>223</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.2478/s13380-012-0032-y</pub-id><pub-id pub-id-type="pmid">23029602</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Kopelkina KJ, Hyman BT, Spires-Jones TL (2012) Soluble forms of tau are toxic in Alzheimer&#x02019;s disease. Transl Neurosci 3:223&#x02013;233. 10.2478/s13380-012-0032-y<pub-id pub-id-type="pmid">23029602</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacs</surname><given-names>GG</given-names></name><name><surname>Lukic</surname><given-names>MJ</given-names></name><name><surname>Irwin</surname><given-names>DJ</given-names></name><name><surname>Arzberger</surname><given-names>T</given-names></name><name><surname>Respondek</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>EB</given-names></name><etal/></person-group><article-title>Distribution patterns of tau pathology in progressive supranuclear palsy</article-title><source>Acta Neuropathol</source><year>2020</year><volume>140</volume><fpage>99</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1007/s00401-020-02158-2</pub-id><pub-id pub-id-type="pmid">32383020</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB et al (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99&#x02013;119. 10.1007/s00401-020-02158-2<pub-id pub-id-type="pmid">32383020</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Lace</surname><given-names>G</given-names></name><name><surname>Savva</surname><given-names>GM</given-names></name><name><surname>Forster</surname><given-names>G</given-names></name><name><surname>de Silva</surname><given-names>R</given-names></name><name><surname>Brayne</surname><given-names>C</given-names></name><name><surname>Matthews</surname><given-names>FE</given-names></name><etal/></person-group><article-title>Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study</article-title><source>Brain</source><year>2009</year><volume>132</volume><fpage>1324</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1093/brain/awp059</pub-id><pub-id pub-id-type="pmid">19321462</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Lace G, Savva GM, Forster G, de Silva R, Brayne C, Matthews FE et al (2009) Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain 132:1324&#x02013;1334. 10.1093/brain/awp059<pub-id pub-id-type="pmid">19321462</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name></person-group><article-title>Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies</article-title><source>Acta Neuropathol</source><year>2016</year><volume>131</volume><fpage>27</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1007/s00401-015-1507-z</pub-id><pub-id pub-id-type="pmid">26576562</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Lewis J, Dickson DW (2016) Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:27&#x02013;48. 10.1007/s00401-015-1507-z<pub-id pub-id-type="pmid">26576562</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Limorenko</surname><given-names>G</given-names></name><name><surname>Lashuel</surname><given-names>HA</given-names></name></person-group><article-title>Revisiting the grammar of tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target tauopathies</article-title><source>Chem Soc Rev</source><year>2022</year><volume>51</volume><fpage>563</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1039/d1cs00127b</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Limorenko G, Lashuel HA (2022) Revisiting the grammar of tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target tauopathies. Chem Soc Rev 51:563&#x02013;565. 10.1039/d1cs00127b</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Lippa</surname><given-names>CF</given-names></name><name><surname>Smith</surname><given-names>TW</given-names></name><name><surname>Saunders</surname><given-names>AM</given-names></name><name><surname>Hulette</surname><given-names>C</given-names></name><name><surname>Pulaski-Salo</surname><given-names>D</given-names></name><name><surname>Roses</surname><given-names>AD</given-names></name></person-group><article-title>Apolipoprotein E-epsilon 2 and Alzheimer&#x02018;s disease: genotype influences pathologic phenotype</article-title><source>Neurology</source><year>1997</year><volume>48</volume><fpage>515</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1212/wnl.48.2.515</pub-id><pub-id pub-id-type="pmid">9040748</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD (1997) Apolipoprotein E-epsilon 2 and Alzheimer&#x02018;s disease: genotype influences pathologic phenotype. Neurology 48:515&#x02013;519. 10.1212/wnl.48.2.515<pub-id pub-id-type="pmid">9040748</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>CC</given-names></name><name><surname>Liu</surname><given-names>CC</given-names></name><name><surname>Kanekiyo</surname><given-names>T</given-names></name><etal/></person-group><article-title>Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy</article-title><source>Nat Rev Neurol</source><year>2013</year><volume>9</volume><fpage>106</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2012.263</pub-id><pub-id pub-id-type="pmid">23296339</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Liu CC, Liu CC, Kanekiyo T et al (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106&#x02013;118. 10.1038/nrneurol.2012.263. (<bold>Erratum.In:NatRevNeurol2013.10.1038/nmeurol.2013.32.Liu,Chia-Chan[correctedtoLiu,Chia-Chen]</bold>)<pub-id pub-id-type="pmid">23296339</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Lumsden</surname><given-names>AL</given-names></name><name><surname>Mulugeta</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>A</given-names></name><name><surname>Hypp&#x000f6;nen</surname><given-names>E</given-names></name></person-group><article-title>Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank</article-title><source>EBioMedicine</source><year>2020</year><volume>59</volume><fpage>102954</fpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2020.102954</pub-id><pub-id pub-id-type="pmid">32818802</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Lumsden AL, Mulugeta A, Zhou A, Hypp&#x000f6;nen E (2020) Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine 59:102954. 10.1016/j.ebiom.2020.102954<pub-id pub-id-type="pmid">32818802</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Mahady</surname><given-names>JJ</given-names></name><name><surname>Perez</surname><given-names>SE</given-names></name><name><surname>Malek-Ahmadi</surname><given-names>M</given-names></name><name><surname>Mufson</surname><given-names>EJ</given-names></name></person-group><article-title>Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer&#x02019;s disease</article-title><source>J Comp Neurol</source><year>2023</year><volume>531</volume><fpage>2080</fpage><lpage>2108</lpage><pub-id pub-id-type="doi">10.1002/cne.25466</pub-id><pub-id pub-id-type="pmid">36989381</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Mahady JJ, Perez SE, Malek-Ahmadi M, Mufson EJ (2023) Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer&#x02019;s disease. J Comp Neurol 531:2080&#x02013;2108. 10.1002/cne.25466<pub-id pub-id-type="pmid">36989381</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Malia</surname><given-names>TJ</given-names></name><name><surname>Teplyakov</surname><given-names>A</given-names></name><name><surname>Ernst</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>SJ</given-names></name><name><surname>Lacy</surname><given-names>ER</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8</article-title><source>Proteins</source><year>2016</year><volume>84</volume><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1002/prot.24988</pub-id><pub-id pub-id-type="pmid">26800003</pub-id>
</element-citation><mixed-citation id="mc-CR87" publication-type="journal">Malia TJ, Teplyakov A, Ernst R, Wu SJ, Lacy ER, Liu X et al (2016) Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8. Proteins 84:427&#x02013;434. 10.1002/prot.24988<pub-id pub-id-type="pmid">26800003</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>McKay</surname><given-names>GJ</given-names></name><name><surname>Silvestri</surname><given-names>G</given-names></name><name><surname>Chakravarthy</surname><given-names>U</given-names></name><name><surname>Dasari</surname><given-names>S</given-names></name><name><surname>Fritsche</surname><given-names>LG</given-names></name><name><surname>Weber</surname><given-names>BH</given-names></name><etal/></person-group><article-title>Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people</article-title><source>Am J Epidemiol</source><year>2011</year><volume>173</volume><fpage>1357</fpage><lpage>1364</lpage><pub-id pub-id-type="doi">10.1093/aje/kwr015</pub-id><pub-id pub-id-type="pmid">21498624</pub-id>
</element-citation><mixed-citation id="mc-CR88" publication-type="journal">McKay GJ, Silvestri G, Chakravarthy U, Dasari S, Fritsche LG, Weber BH et al (2011) Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol 173:1357&#x02013;1364. 10.1093/aje/kwr015<pub-id pub-id-type="pmid">21498624</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>McKee</surname><given-names>AC</given-names></name><name><surname>Stern</surname><given-names>RA</given-names></name><name><surname>Nowinski</surname><given-names>CJ</given-names></name><name><surname>Stein</surname><given-names>TD</given-names></name><name><surname>Alvarez</surname><given-names>VE</given-names></name><name><surname>Daneshvar</surname><given-names>DH</given-names></name><etal/></person-group><article-title>The spectrum of disease in chronic traumatic encephalopathy</article-title><source>Brain</source><year>2013</year><volume>136</volume><fpage>43</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1093/brain/aws307</pub-id><pub-id pub-id-type="pmid">23208308</pub-id>
</element-citation><mixed-citation id="mc-CR89" publication-type="journal">McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH et al (2013) The spectrum of disease in chronic traumatic encephalopathy. Brain 136:43&#x02013;64. 10.1093/brain/aws307<pub-id pub-id-type="pmid">23208308</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>McMillan</surname><given-names>CT</given-names></name><name><surname>Lee</surname><given-names>EB</given-names></name><name><surname>Jefferson-George</surname><given-names>K</given-names></name><name><surname>Naj</surname><given-names>A</given-names></name><name><surname>Van Deerlin</surname><given-names>VM</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><etal/></person-group><article-title>Alzheimer's genetic risk is reduced in primary age-related tauopathy: a potential model of resistance?</article-title><source>Ann Clin Transl Neurol</source><year>2018</year><volume>5</volume><fpage>927</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1002/acn3.581</pub-id><pub-id pub-id-type="pmid">30128317</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">McMillan CT, Lee EB, Jefferson-George K, Naj A, Van Deerlin VM, Trojanowski JQ et al (2018) Alzheimer&#x02019;s genetic risk is reduced in primary age-related tauopathy: a potential model of resistance? Ann Clin Transl Neurol 5:927&#x02013;934. 10.1002/acn3.581<pub-id pub-id-type="pmid">30128317</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Merino-Serrais</surname><given-names>P</given-names></name><name><surname>Benavides-Piccione</surname><given-names>R</given-names></name><name><surname>Blazquez-Llorca</surname><given-names>L</given-names></name><name><surname>Kastanauskaite</surname><given-names>A</given-names></name><name><surname>Rabano</surname><given-names>A</given-names></name><name><surname>Avila</surname><given-names>J</given-names></name><etal/></person-group><article-title>The influence of phospho-&#x003c4; on dendritic spines of cortical pyramidal neurons in patients with Alzheimer&#x02019;s disease</article-title><source>Brain</source><year>2013</year><volume>136</volume><fpage>1913</fpage><lpage>1928</lpage><pub-id pub-id-type="doi">10.1093/brain/awt088</pub-id><pub-id pub-id-type="pmid">23715095</pub-id>
</element-citation><mixed-citation id="mc-CR91" publication-type="journal">Merino-Serrais P, Benavides-Piccione R, Blazquez-Llorca L, Kastanauskaite A, Rabano A, Avila J et al (2013) The influence of phospho-&#x003c4; on dendritic spines of cortical pyramidal neurons in patients with Alzheimer&#x02019;s disease. Brain 136:1913&#x02013;1928. 10.1093/brain/awt088<pub-id pub-id-type="pmid">23715095</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name><surname>Milenkovic</surname><given-names>I</given-names></name><name><surname>Petrov</surname><given-names>T</given-names></name><name><surname>Kovacs</surname><given-names>GG</given-names></name></person-group><article-title>Patterns of hippocampal tau pathology differentiate neurodegenerative dementias</article-title><source>Dementia Geriatr Cogn Disord</source><year>2014</year><volume>38</volume><fpage>375</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1159/000365548</pub-id></element-citation><mixed-citation id="mc-CR92" publication-type="journal">Milenkovic I, Petrov T, Kovacs GG (2014) Patterns of hippocampal tau pathology differentiate neurodegenerative dementias. Dementia Geriatr Cogn Disord 38:375&#x02013;388. 10.1159/000365548</mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name><surname>Morsch</surname><given-names>R</given-names></name><name><surname>Simon</surname><given-names>W</given-names></name><name><surname>Coleman</surname><given-names>PD</given-names></name></person-group><article-title>Neurons may live for decades with neurofibrillary tangles</article-title><source>J Neuropathol Exp Neurol</source><year>1999</year><volume>58</volume><fpage>188</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1097/00005072-199902000-00008</pub-id><pub-id pub-id-type="pmid">10029101</pub-id>
</element-citation><mixed-citation id="mc-CR93" publication-type="journal">Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58:188&#x02013;197. 10.1097/00005072-199902000-00008<pub-id pub-id-type="pmid">10029101</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name><surname>Mudher</surname><given-names>A</given-names></name><name><surname>Colin</surname><given-names>M</given-names></name><name><surname>Dujardin</surname><given-names>S</given-names></name><name><surname>Medina</surname><given-names>M</given-names></name><name><surname>Dewachter</surname><given-names>I</given-names></name><name><surname>Alavi Naini</surname><given-names>SM</given-names></name><etal/></person-group><article-title>What is the evidence that tau pathology spreads through prion-like propagation?</article-title><source>Acta Neuropathol Commun</source><year>2017</year><volume>5</volume><fpage>99</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1186/s40478-017-0488-7</pub-id><pub-id pub-id-type="pmid">29258615</pub-id>
</element-citation><mixed-citation id="mc-CR94" publication-type="journal">Mudher A, Colin M, Dujardin S, Medina M, Dewachter I, Alavi Naini SM et al (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5:99&#x02013;119. 10.1186/s40478-017-0488-7<pub-id pub-id-type="pmid">29258615</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name><surname>Ohm</surname><given-names>TG</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Bohl</surname><given-names>J</given-names></name></person-group><article-title>Close-meshed prevalence rates of different stages as a tool to unvover the rate of Alzheimer&#x02019;s disease-related neurofibrillary changes</article-title><source>Neurosci</source><year>1995</year><volume>64</volume><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(95)90397-p</pub-id></element-citation><mixed-citation id="mc-CR95" publication-type="journal">Ohm TG, M&#x000fc;ller H, Braak H, Bohl J (1995) Close-meshed prevalence rates of different stages as a tool to unvover the rate of Alzheimer&#x02019;s disease-related neurofibrillary changes. Neurosci 64:209&#x02013;217. 10.1016/0306-4522(95)90397-p</mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name><surname>Olbrich</surname><given-names>HG</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name></person-group><article-title>Ratio of pyramidal cells versus non-pyramidal cells in sector CA1 of the human Ammon&#x02019;s horn</article-title><source>Anat Embryol</source><year>1985</year><volume>173</volume><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1007/BF00707308</pub-id></element-citation><mixed-citation id="mc-CR96" publication-type="journal">Olbrich HG, Braak H (1985) Ratio of pyramidal cells versus non-pyramidal cells in sector CA1 of the human Ammon&#x02019;s horn. Anat Embryol 173:105&#x02013;110. 10.1007/BF00707308</mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name><surname>Oveisgharan</surname><given-names>S</given-names></name><name><surname>Buchman</surname><given-names>AS</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Farfel</surname><given-names>J</given-names></name><name><surname>Hachinski</surname><given-names>V</given-names></name><name><surname>Gaiteri</surname><given-names>C</given-names></name><etal/></person-group><article-title><italic>APOE</italic> &#x003b5;2&#x003b5;4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults</article-title><source>Neurology</source><year>2018</year><volume>90</volume><fpage>e2127</fpage><lpage>e2134</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000005677</pub-id><pub-id pub-id-type="pmid">29752306</pub-id>
</element-citation><mixed-citation id="mc-CR97" publication-type="journal">Oveisgharan S, Buchman AS, Yu L, Farfel J, Hachinski V, Gaiteri C et al (2018) <italic>APOE</italic> &#x003b5;2&#x003b5;4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology 90:e2127&#x02013;e2134. 10.1212/WNL.0000000000005677<pub-id pub-id-type="pmid">29752306</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name><surname>Palmqvist</surname><given-names>S</given-names></name><name><surname>Janelidze</surname><given-names>S</given-names></name><name><surname>Quiroz</surname><given-names>YT</given-names></name><name><surname>Zetterberg</surname><given-names>H</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name><name><surname>Stomrud</surname><given-names>E</given-names></name><etal/></person-group><article-title>Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs. Other neurodegenerative disorders</article-title><source>JAMA</source><year>2020</year><volume>324</volume><fpage>772</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.12134</pub-id><pub-id pub-id-type="pmid">32722745</pub-id>
</element-citation><mixed-citation id="mc-CR98" publication-type="journal">Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E et al (2020) Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs. Other neurodegenerative disorders. JAMA 324:772&#x02013;781. 10.1001/jama.2020.12134<pub-id pub-id-type="pmid">32722745</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name><surname>Pankratz</surname><given-names>N</given-names></name><name><surname>Byder</surname><given-names>L</given-names></name><name><surname>Halter</surname><given-names>C</given-names></name><name><surname>Rudolph</surname><given-names>A</given-names></name><name><surname>Shults</surname><given-names>CW</given-names></name><name><surname>Conneally</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Presence of an APOE4 allele results in significantly earlier onset of Parkinson&#x02019;s disease and a higher risk with dementia</article-title><source>Mov Disord</source><year>2006</year><volume>21</volume><fpage>45</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1002/mds.20663</pub-id><pub-id pub-id-type="pmid">16116614</pub-id>
</element-citation><mixed-citation id="mc-CR99" publication-type="journal">Pankratz N, Byder L, Halter C, Rudolph A, Shults CW, Conneally PM et al (2006) Presence of an APOE4 allele results in significantly earlier onset of Parkinson&#x02019;s disease and a higher risk with dementia. Mov Disord 21:45&#x02013;49. 10.1002/mds.20663<pub-id pub-id-type="pmid">16116614</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name><surname>Patthy</surname><given-names>A</given-names></name><name><surname>Murai</surname><given-names>J</given-names></name><name><surname>Hanics</surname><given-names>J</given-names></name><name><surname>Pinter</surname><given-names>A</given-names></name><name><surname>Zahola</surname><given-names>P</given-names></name><name><surname>H&#x000f6;kfelt</surname><given-names>TGM</given-names></name><etal/></person-group><article-title>Neuropathology of the brainstem to mechanistically understand and to treat Alzheimer&#x000b4;s disease</article-title><source>J Clin Med</source><year>2021</year><volume>10</volume><fpage>1555</fpage><lpage>1578</lpage><pub-id pub-id-type="doi">10.3390/jcm10081555</pub-id><pub-id pub-id-type="pmid">33917176</pub-id>
</element-citation><mixed-citation id="mc-CR100" publication-type="journal">Patthy A, Murai J, Hanics J, Pinter A, Zahola P, H&#x000f6;kfelt TGM et al (2021) Neuropathology of the brainstem to mechanistically understand and to treat Alzheimer&#x000b4;s disease. J Clin Med 10:1555&#x02013;1578. 10.3390/jcm10081555<pub-id pub-id-type="pmid">33917176</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name><surname>Polvikoski</surname><given-names>T</given-names></name><name><surname>Sulkava</surname><given-names>R</given-names></name><name><surname>Haltia</surname><given-names>M</given-names></name><name><surname>Kainulainen</surname><given-names>K</given-names></name><name><surname>Vuorio</surname><given-names>A</given-names></name><name><surname>Verkkoniemi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein</article-title><source>N Engl J Med</source><year>1995</year><volume>333</volume><fpage>1242</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1056/NEJM199511093331902</pub-id><pub-id pub-id-type="pmid">7566000</pub-id>
</element-citation><mixed-citation id="mc-CR101" publication-type="journal">Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A et al (1995) Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 333:1242&#x02013;1247. 10.1056/NEJM199511093331902<pub-id pub-id-type="pmid">7566000</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Wolters</surname><given-names>FJ</given-names></name><name><surname>Beiser</surname><given-names>A</given-names></name><etal/></person-group><article-title>APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts</article-title><source>PLoS Med</source><year>2017</year><volume>14</volume><fpage>e1002254</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1002254</pub-id><pub-id pub-id-type="pmid">28323826</pub-id>
</element-citation><mixed-citation id="mc-CR102" publication-type="journal">Qian J, Wolters FJ, Beiser A et al (2017) APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts. PLoS Med 14:e1002254. 10.1371/journal.pmed.1002254<pub-id pub-id-type="pmid">28323826</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name><surname>Rahimi</surname><given-names>J</given-names></name><name><surname>Kovacs</surname><given-names>GG</given-names></name></person-group><article-title>Prevalence of mixed pathologies in the aging brain</article-title><source>Alzheimers Res Ther</source><year>2014</year><volume>6</volume><fpage>82</fpage><pub-id pub-id-type="doi">10.1186/s13195-014-0082-1</pub-id><pub-id pub-id-type="pmid">25419243</pub-id>
</element-citation><mixed-citation id="mc-CR103" publication-type="journal">Rahimi J, Kovacs GG (2014) Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther 6:82. 10.1186/s13195-014-0082-1<pub-id pub-id-type="pmid">25419243</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name><surname>Rubinski</surname><given-names>A</given-names></name><name><surname>Franzmeier</surname><given-names>N</given-names></name><name><surname>Dewenter</surname><given-names>A</given-names></name><name><surname>Luan</surname><given-names>Y</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Strandberg</surname><given-names>O</given-names></name><etal/></person-group><article-title>Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's disease</article-title><source>Alzheimers Res Ther</source><year>2022</year><volume>14</volume><fpage>139</fpage><pub-id pub-id-type="doi">10.1186/s13195-022-01074-9</pub-id><pub-id pub-id-type="pmid">36153607</pub-id>
</element-citation><mixed-citation id="mc-CR104" publication-type="journal">Rubinski A, Franzmeier N, Dewenter A, Luan Y, Smith R, Strandberg O et al (2022) Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer&#x02019;s disease. Alzheimers Res Ther 14:139. 10.1186/s13195-022-01074-9<pub-id pub-id-type="pmid">36153607</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name><surname>Saper</surname><given-names>CB</given-names></name><name><surname>Wainer</surname><given-names>BH</given-names></name><name><surname>German</surname><given-names>DC</given-names></name></person-group><article-title>Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer&#x02019;s disease</article-title><source>Neuroscience</source><year>1987</year><volume>23</volume><fpage>3893</fpage><lpage>3898</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(87)90063-7</pub-id></element-citation><mixed-citation id="mc-CR105" publication-type="journal">Saper CB, Wainer BH, German DC (1987) Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer&#x02019;s disease. Neuroscience 23:3893&#x02013;3898. 10.1016/0306-4522(87)90063-7</mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name><surname>Scharfman</surname><given-names>HE</given-names></name></person-group><article-title>Advances in understanding hilar mossy cells of the dentate gyrus</article-title><source>Cell Tiss Res</source><year>2018</year><volume>373</volume><fpage>643</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1007/s00441-017-2750-5</pub-id></element-citation><mixed-citation id="mc-CR106" publication-type="journal">Scharfman HE (2018) Advances in understanding hilar mossy cells of the dentate gyrus. Cell Tiss Res 373:643&#x02013;652. 10.1007/s00441-017-2750-5</mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000f6;nheit</surname><given-names>B</given-names></name><name><surname>Zarski</surname><given-names>R</given-names></name><name><surname>Ohm</surname><given-names>TG</given-names></name></person-group><article-title>Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology</article-title><source>Neurobiol Aging</source><year>2004</year><volume>25</volume><fpage>697</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2003.09.009</pub-id><pub-id pub-id-type="pmid">15165691</pub-id>
</element-citation><mixed-citation id="mc-CR107" publication-type="journal">Sch&#x000f6;nheit B, Zarski R, Ohm TG (2004) Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25:697&#x02013;711. 10.1016/j.neurobiolaging.2003.09.009<pub-id pub-id-type="pmid">15165691</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name><surname>Selkoe</surname><given-names>DJ</given-names></name></person-group><article-title>The molecular pathology of Alzheimer&#x02019;s disease</article-title><source>Neuron</source><year>1991</year><volume>6</volume><fpage>487</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(91)90052-2</pub-id><pub-id pub-id-type="pmid">1673054</pub-id>
</element-citation><mixed-citation id="mc-CR108" publication-type="journal">Selkoe DJ (1991) The molecular pathology of Alzheimer&#x02019;s disease. Neuron 6:487&#x02013;498. 10.1016/0896-6273(91)90052-2<pub-id pub-id-type="pmid">1673054</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Liddelow</surname><given-names>SA</given-names></name><name><surname>Smith</surname><given-names>ST</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><etal/></person-group><article-title>ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy</article-title><source>Nature</source><year>2017</year><volume>549</volume><fpage>523</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/nature24016</pub-id><pub-id pub-id-type="pmid">28959956</pub-id>
</element-citation><mixed-citation id="mc-CR109" publication-type="journal">Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W et al (2017) ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549:523&#x02013;527. 10.1038/nature24016<pub-id pub-id-type="pmid">28959956</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>MG</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name></person-group><article-title>Tau pathology and neurodegeneration</article-title><source>Lancet Neurol</source><year>2013</year><volume>12</volume><fpage>609</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(13)70090-5</pub-id><pub-id pub-id-type="pmid">23684085</pub-id>
</element-citation><mixed-citation id="mc-CR110" publication-type="journal">Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609&#x02013;622. 10.1016/S1474-4422(13)70090-5<pub-id pub-id-type="pmid">23684085</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><citation-alternatives><element-citation id="ec-CR111" publication-type="journal"><person-group person-group-type="author"><name><surname>Stratmann</surname><given-names>K</given-names></name><name><surname>Heinsen</surname><given-names>H</given-names></name><name><surname>Korf</surname><given-names>HW</given-names></name><name><surname>Del Turco</surname><given-names>D</given-names></name><name><surname>Ghebremedhin</surname><given-names>E</given-names></name><name><surname>Seidel</surname><given-names>K</given-names></name><etal/></person-group><article-title>Precortical phase of Alzheimer&#x02019;s disease (AD)-related tau cytoskeletal pathology</article-title><source>Brain Pathol</source><year>2016</year><volume>26</volume><fpage>371</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1111/bpa.12289</pub-id><pub-id pub-id-type="pmid">26193084</pub-id>
</element-citation><mixed-citation id="mc-CR111" publication-type="journal">Stratmann K, Heinsen H, Korf HW, Del Turco D, Ghebremedhin E, Seidel K et al (2016) Precortical phase of Alzheimer&#x02019;s disease (AD)-related tau cytoskeletal pathology. Brain Pathol 26:371&#x02013;386. 10.1111/bpa.12289<pub-id pub-id-type="pmid">26193084</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name><surname>Stricker</surname><given-names>NH</given-names></name><name><surname>Schweinsburg</surname><given-names>BC</given-names></name><name><surname>Delano-Wood</surname><given-names>L</given-names></name><name><surname>Wierenga</surname><given-names>CE</given-names></name><name><surname>Bangen</surname><given-names>KJ</given-names></name><name><surname>Haaland</surname><given-names>KY</given-names></name><etal/></person-group><article-title>Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer&#x02019;s disease supports retrogenesis</article-title><source>Neuroimage</source><year>2009</year><volume>45</volume><fpage>10</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.11.027</pub-id><pub-id pub-id-type="pmid">19100839</pub-id>
</element-citation><mixed-citation id="mc-CR112" publication-type="journal">Stricker NH, Schweinsburg BC, Delano-Wood L, Wierenga CE, Bangen KJ, Haaland KY et al (2009) Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer&#x02019;s disease supports retrogenesis. Neuroimage 45:10&#x02013;16. 10.1016/j.neuroimage.2008.11.027<pub-id pub-id-type="pmid">19100839</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>HC</given-names></name><name><surname>Serrano-Pozo</surname><given-names>A</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Frosch</surname><given-names>M</given-names></name><name><surname>Spires-Jones</surname><given-names>TL</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><article-title>The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system</article-title><source>Am J Pathol</source><year>2012</year><volume>181</volume><fpage>14263</fpage><lpage>14265</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2012.06.033</pub-id></element-citation><mixed-citation id="mc-CR113" publication-type="journal">Tai HC, Serrano-Pozo A, Hashimoto T, Frosch M, Spires-Jones TL, Hyman BT (2012) The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol 181:14263&#x02013;14265. 10.1016/j.ajpath.2012.06.033. (<bold>Erratum.In:AmJPathol2012;181:1889-1890</bold>)</mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name><surname>Tashiro</surname><given-names>K</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Ihara</surname><given-names>Y</given-names></name><name><surname>Iwatsubo</surname><given-names>T</given-names></name></person-group><article-title>Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex</article-title><source>NeuroReport</source><year>1997</year><volume>8</volume><fpage>2797</fpage><lpage>2801</lpage><pub-id pub-id-type="doi">10.1097/00001756-199708180-00029</pub-id><pub-id pub-id-type="pmid">9295120</pub-id>
</element-citation><mixed-citation id="mc-CR114" publication-type="journal">Tashiro K, Hasegawa M, Ihara Y, Iwatsubo T (1997) Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex. NeuroReport 8:2797&#x02013;2801. 10.1097/00001756-199708180-00029<pub-id pub-id-type="pmid">9295120</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><citation-alternatives><element-citation id="ec-CR115" publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>KI</given-names></name><name><surname>Probst</surname><given-names>A</given-names></name></person-group><article-title>Anatomic localization of the transentorhinal region of the perirhinal cortex</article-title><source>Neurobiol Aging</source><year>2008</year><volume>29</volume><fpage>1591</fpage><lpage>1596</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2007.03.024</pub-id><pub-id pub-id-type="pmid">17478012</pub-id>
</element-citation><mixed-citation id="mc-CR115" publication-type="journal">Taylor KI, Probst A (2008) Anatomic localization of the transentorhinal region of the perirhinal cortex. Neurobiol Aging 29:1591&#x02013;1596. 10.1016/j.neurobiolaging.2007.03.024<pub-id pub-id-type="pmid">17478012</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name><surname>Therriault</surname><given-names>J</given-names></name><name><surname>Pascoal</surname><given-names>TA</given-names></name><name><surname>Lussier</surname><given-names>FZ</given-names></name><name><surname>Tissot</surname><given-names>C</given-names></name><name><surname>Chamoun</surname><given-names>M</given-names></name><name><surname>Bezgin</surname><given-names>G</given-names></name><etal/></person-group><article-title>Biomarker modeling of Alzheimer&#x02019;s disease using PET-based Braak staging</article-title><source>Nat Aging</source><year>2022</year><volume>2</volume><fpage>526</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1038/s43587-022-00204-0</pub-id><pub-id pub-id-type="pmid">37118445</pub-id>
</element-citation><mixed-citation id="mc-CR116" publication-type="journal">Therriault J, Pascoal TA, Lussier FZ, Tissot C, Chamoun M, Bezgin G et al (2022) Biomarker modeling of Alzheimer&#x02019;s disease using PET-based Braak staging. Nat Aging 2:526&#x02013;535. 10.1038/s43587-022-00204-0<pub-id pub-id-type="pmid">37118445</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name><surname>Tiraboschi</surname><given-names>P</given-names></name><name><surname>Hansen</surname><given-names>LA</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name><name><surname>Alford</surname><given-names>M</given-names></name><name><surname>Thal</surname><given-names>LJ</given-names></name><name><surname>Corey-Bloom</surname><given-names>J</given-names></name></person-group><article-title>Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease</article-title><source>Neurology</source><year>2004</year><volume>62</volume><fpage>1977</fpage><lpage>1983</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000128091.92139.0f</pub-id><pub-id pub-id-type="pmid">15184600</pub-id>
</element-citation><mixed-citation id="mc-CR117" publication-type="journal">Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 62:1977&#x02013;1983. 10.1212/01.wnl.0000128091.92139.0f<pub-id pub-id-type="pmid">15184600</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><citation-alternatives><element-citation id="ec-CR118" publication-type="journal"><person-group person-group-type="author"><name><surname>Tsamis</surname><given-names>IK</given-names></name><name><surname>Mytillinaios</surname><given-names>GD</given-names></name><name><surname>Njau</surname><given-names>NS</given-names></name><name><surname>Toiou</surname><given-names>FD</given-names></name><name><surname>Glaftsi</surname><given-names>S</given-names></name><name><surname>Costa</surname><given-names>V</given-names></name><etal/></person-group><article-title>Properties of CA3 dendritic excrescences in Alzheimer&#x02019;s disease</article-title><source>Curr Alzheimer Res</source><year>2020</year><volume>1</volume><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.2174/156720510790274482</pub-id></element-citation><mixed-citation id="mc-CR118" publication-type="journal">Tsamis IK, Mytillinaios GD, Njau NS, Toiou FD, Glaftsi S, Costa V et al (2020) Properties of CA3 dendritic excrescences in Alzheimer&#x02019;s disease. Curr Alzheimer Res 1:84&#x02013;90. 10.2174/156720510790274482</mixed-citation></citation-alternatives></ref><ref id="CR119"><label>119.</label><citation-alternatives><element-citation id="ec-CR119" publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuang</surname><given-names>D</given-names></name><name><surname>Leverenz</surname><given-names>JB</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>Hamilton</surname><given-names>RL</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Schneider</surname><given-names>JA</given-names></name><etal/></person-group><article-title>APOE &#x003b5;4 increases risk for dementia in pure synucleinopathies</article-title><source>JAMA Neurol</source><year>2013</year><volume>70</volume><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2013.600</pub-id><pub-id pub-id-type="pmid">23407718</pub-id>
</element-citation><mixed-citation id="mc-CR119" publication-type="journal">Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA et al (2013) APOE &#x003b5;4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70:223&#x02013;228. 10.1001/jamaneurol.2013.600<pub-id pub-id-type="pmid">23407718</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR120"><label>120.</label><citation-alternatives><element-citation id="ec-CR120" publication-type="journal"><person-group person-group-type="author"><name><surname>Uchihara</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>A</given-names></name><name><surname>Yamazaki</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>O</given-names></name></person-group><article-title>Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence</article-title><source>Acta Neuropathol</source><year>2001</year><volume>101</volume><fpage>535</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1007/s004010000306</pub-id><pub-id pub-id-type="pmid">11515780</pub-id>
</element-citation><mixed-citation id="mc-CR120" publication-type="journal">Uchihara T, Nakamura A, Yamazaki M, Mori O (2001) Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol 101:535&#x02013;539. 10.1007/s004010000306<pub-id pub-id-type="pmid">11515780</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR121"><label>121.</label><citation-alternatives><element-citation id="ec-CR121" publication-type="journal"><person-group person-group-type="author"><name><surname>Valero</surname><given-names>M</given-names></name><name><surname>Menendez de la Prida</surname><given-names>L</given-names></name></person-group><article-title>The hippocampus in depth: a sublayer-specific perspective of entorhinal-hippocampal function</article-title><source>Curr Opin Neurobiol</source><year>2018</year><volume>52</volume><fpage>107</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.04.013</pub-id><pub-id pub-id-type="pmid">29729527</pub-id>
</element-citation><mixed-citation id="mc-CR121" publication-type="journal">Valero M, Menendez de la Prida L (2018) The hippocampus in depth: a sublayer-specific perspective of entorhinal-hippocampal function. Curr Opin Neurobiol 52:107&#x02013;114. 10.1016/j.conb.2018.04.013<pub-id pub-id-type="pmid">29729527</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR122"><label>122.</label><citation-alternatives><element-citation id="ec-CR122" publication-type="journal"><person-group person-group-type="author"><name><surname>Van Hoesen</surname><given-names>GW</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><article-title>Hippocampal formation: anatomy and the patterns of pathology in Alzheimer&#x02019;s disease</article-title><source>Prog Brain Res</source><year>1990</year><volume>83</volume><fpage>445</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/s0079-6123(08)61268-6</pub-id><pub-id pub-id-type="pmid">2392569</pub-id>
</element-citation><mixed-citation id="mc-CR122" publication-type="journal">Van Hoesen GW, Hyman BT (1990) Hippocampal formation: anatomy and the patterns of pathology in Alzheimer&#x02019;s disease. Prog Brain Res 83:445&#x02013;457. 10.1016/s0079-6123(08)61268-6<pub-id pub-id-type="pmid">2392569</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR123"><label>123.</label><citation-alternatives><element-citation id="ec-CR123" publication-type="journal"><person-group person-group-type="author"><name><surname>Velasco</surname><given-names>ME</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name><name><surname>Siedlak</surname><given-names>SI</given-names></name><name><surname>Nunomura</surname><given-names>A</given-names></name><name><surname>Perry</surname><given-names>G</given-names></name></person-group><article-title>Striation is the characteristic neuritic abnormality in Alzheimer disease</article-title><source>Brain Res</source><year>1998</year><volume>813</volume><fpage>329</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/s0006-8993(98)01034-8</pub-id><pub-id pub-id-type="pmid">9838181</pub-id>
</element-citation><mixed-citation id="mc-CR123" publication-type="journal">Velasco ME, Smith MA, Siedlak SI, Nunomura A, Perry G (1998) Striation is the characteristic neuritic abnormality in Alzheimer disease. Brain Res 813:329&#x02013;333. 10.1016/s0006-8993(98)01034-8<pub-id pub-id-type="pmid">9838181</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR124"><label>124.</label><citation-alternatives><element-citation id="ec-CR124" publication-type="journal"><person-group person-group-type="author"><name><surname>Vogels</surname><given-names>T</given-names></name><name><surname>Lenzy</surname><given-names>A</given-names></name><name><surname>Cicognolla</surname><given-names>C</given-names></name><name><surname>Ashton</surname><given-names>NJ</given-names></name><name><surname>Smolek</surname><given-names>T</given-names></name><name><surname>Novak</surname><given-names>M</given-names></name><etal/></person-group><article-title>Propagation of tau pathology: insights from postmortem an in vivo studies</article-title><source>Biol Psychiatry</source><year>2020</year><volume>87</volume><fpage>808</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2019.09.019</pub-id><pub-id pub-id-type="pmid">31735253</pub-id>
</element-citation><mixed-citation id="mc-CR124" publication-type="journal">Vogels T, Lenzy A, Cicognolla C, Ashton NJ, Smolek T, Novak M et al (2020) Propagation of tau pathology: insights from postmortem an in vivo studies. Biol Psychiatry 87:808&#x02013;818. 10.1016/j.biopsych.2019.09.019<pub-id pub-id-type="pmid">31735253</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR125"><label>125.</label><citation-alternatives><element-citation id="ec-CR125" publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>A</given-names></name><name><surname>Crean</surname><given-names>S</given-names></name><name><surname>Mercaldi</surname><given-names>CJ</given-names></name><name><surname>Collins</surname><given-names>JM</given-names></name><name><surname>Boyd</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>MN</given-names></name><etal/></person-group><article-title>Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer&#x02019;s disease: a systematic review and metaanalysis</article-title><source>Neuroepidemiology</source><year>2012</year><volume>38</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1159/000334607</pub-id><pub-id pub-id-type="pmid">22179327</pub-id>
</element-citation><mixed-citation id="mc-CR125" publication-type="journal">Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN et al (2012) Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer&#x02019;s disease: a systematic review and metaanalysis. Neuroepidemiology 38:1&#x02013;17. 10.1159/000334607<pub-id pub-id-type="pmid">22179327</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR126"><label>126.</label><citation-alternatives><element-citation id="ec-CR126" publication-type="journal"><person-group person-group-type="author"><name><surname>Wenneberg</surname><given-names>AM</given-names></name><name><surname>Tosakulwong</surname><given-names>N</given-names></name><name><surname>Lesnick</surname><given-names>TG</given-names></name><name><surname>Murray</surname><given-names>ME</given-names></name><name><surname>Whitwell</surname><given-names>JL</given-names></name><name><surname>Liesinger</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Association of apolipoprotein E &#x003b5;4 with transactive response DNA-binding protein 43</article-title><source>JAMA Neurol</source><year>2018</year><volume>75</volume><fpage>1347</fpage><lpage>1354</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2018.3139</pub-id><pub-id pub-id-type="pmid">30422173</pub-id>
</element-citation><mixed-citation id="mc-CR126" publication-type="journal">Wenneberg AM, Tosakulwong N, Lesnick TG, Murray ME, Whitwell JL, Liesinger AM et al (2018) Association of apolipoprotein E &#x003b5;4 with transactive response DNA-binding protein 43. JAMA Neurol 75:1347&#x02013;1354. 10.1001/jamaneurol.2018.3139<pub-id pub-id-type="pmid">30422173</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR127"><label>127.</label><citation-alternatives><element-citation id="ec-CR127" publication-type="journal"><person-group person-group-type="author"><name><surname>Witter</surname><given-names>MP</given-names></name></person-group><article-title>The perforant path: projections from the entorhinal cortex to the dentate gyrus</article-title><source>Prog Brain Res</source><year>2007</year><volume>163</volume><fpage>43</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S0079-6123(07)63003-9</pub-id><pub-id pub-id-type="pmid">17765711</pub-id>
</element-citation><mixed-citation id="mc-CR127" publication-type="journal">Witter MP (2007) The perforant path: projections from the entorhinal cortex to the dentate gyrus. Prog Brain Res 163:43&#x02013;61. 10.1016/S0079-6123(07)63003-9<pub-id pub-id-type="pmid">17765711</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR128"><label>128.</label><citation-alternatives><element-citation id="ec-CR128" publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Prokop</surname><given-names>S</given-names></name><name><surname>Gorion</surname><given-names>KM</given-names></name><name><surname>Kim</surname><given-names>JD</given-names></name><name><surname>Sorrentino</surname><given-names>ZA</given-names></name><name><surname>Bell</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies</article-title><source>Acta Neuropathol Commun</source><year>2020</year><volume>8</volume><fpage>88</fpage><pub-id pub-id-type="doi">10.1186/s40478-020-00967-w</pub-id><pub-id pub-id-type="pmid">32571418</pub-id>
</element-citation><mixed-citation id="mc-CR128" publication-type="journal">Xia Y, Prokop S, Gorion KM, Kim JD, Sorrentino ZA, Bell BM et al (2020) Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer&#x02019;s disease and other tauopathies. Acta Neuropathol Commun 8:88. 10.1186/s40478-020-00967-w<pub-id pub-id-type="pmid">32571418</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR129"><label>129.</label><citation-alternatives><element-citation id="ec-CR129" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><etal/></person-group><article-title>Quantitative assessment of hippocampal tau pathology in AD and PART</article-title><source>J Mol Neurosci</source><year>2020</year><volume>70</volume><fpage>1808</fpage><lpage>1811</lpage><pub-id pub-id-type="doi">10.1007/s12031-020-01573-0</pub-id><pub-id pub-id-type="pmid">32372343</pub-id>
</element-citation><mixed-citation id="mc-CR129" publication-type="journal">Zhang L, Jiang Y, Zhu J, Liang H, He X, Qian J et al (2020) Quantitative assessment of hippocampal tau pathology in AD and PART. J Mol Neurosci 70:1808&#x02013;1811. 10.1007/s12031-020-01573-0<pub-id pub-id-type="pmid">32372343</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>